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thereof are disclosed. Their method of preparation and 
use as antiarrhythmic agents is given. 
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3-7-DIHETERABICYCL0[3.3.l]NONANES AS 
ANTIARRHYTHMIC AGENTS 
This is a divisional of co-pending application Ser. No. 5 
07/048/325 filed on May 11, 1987 now U.S. Pat. No. 
4,778,892. 
BACKGROUND OF THE INVENTION 
(I) 
1. Field of the Invention: 10 where Ar is: 
This invention relates to antiarrhythmic composi-
tions. More specifically, the invention relates to certain 
3-7-diheterabicyclo[3.3. l]nonanes and derivatives 
thereof. 
2. Description of the Prior Art: 15 -0 -0-CH,-Q 
3-azabicyclo[3.3. l]nonanes, including bicyclic sys-
tems with one heteroatom such as N, Sand O and vari-
ous derivatives, are known and are documented in the 
chemical literature. In a Chemical Reviews article, 
1981, Vol. 81, No. 2, pages 149-174, entitled "Chemis- 20 
try of 3-Azabicyclo[3.3.l]nonanes" by R. Jeyaraman 
and S. Avila the synthesis, stereochemistry, and reac-
tions of such compounds are reviewed. This article 
acknowledges the close resemblence of aza- and 
diazaadamantanes in conformation and stereochemistry 25 
to the 3-azabicyclo[3.3. l]nonanes as a cause for signifi-
cant progess in the azabicyclononane (ABN) studies. 
The article further acknowledges the ease of formation 
of 3-ABNs from simple ketones and aldehydes through 30 the Mannich reaction without the involvement of com-
pl_icated reaction conditions and reagents and the ready 
availability of a reactive carbonyl group in most of the 
ABNs prepared as important reasons for widespread 
studies on ABNs. 35 
According to the existing chemical literature, some 
derivatives of 3-ABN have been found to possess useful 
biological activities. The observed biological activies 
have included potent analgesic properties and antitusive 
activities as wen as antagonism to analgesic effects and 40 
even weak narcotic antagonism depending on the par-
ticular compound involved. Some have displayed local 
anesthetic activity and simple 3-ABN is reportedly ef-
fective against influenza infection. Other derivatives of 
3-ABN have displayed powerful ganglioplegic and 45 
hypotensive properties. Several have been found to be 
sedatives, antipyretics, and psycholaleptic and hypogly-
cemic agents. Some 3,7-diazabicyclo[3.3. l]nonanes pos-
sess antiarrhythmic potencies. 
The Chemical Reviews article further described the so 
subclass of 3-thia-7-azabicyclo[3.3. l ]nonanes as being of 
much··less interest and identifies a series of diphenyl 
and/or diary! substituted derivatives as having been 
prepared through the Mannich reaction. In U.S. Pat. 
No. 4,581,361 certain 3-thia-7-azabicyclo[3.3. l]nonanes 55 
and derivatives are disclosed and claimed as antiar-
rhythmic compounds. 
SUMMARY OF THE INVENTION 
The present invention involves novel 3,7- 60 
diheterabicyclo[3.3. l]nonanes contammg more than 
one heteroatom such as Se, N, Sand 0. In particular the 
invention involves novel 3-selena-7-azabicyclo[3.3. l-
]nonanes, corresponding nitrogen compounds, related 
polyheterotricyclo compounds and derivatives thereof. 65 
Thus the present invention provides novel 3-selena-7-
azabicyclo[3.3. l ]nonane~9-one compounds having the 
formula: 
-CH,-Oocn," -cn,-Q-ocn, 
OCH3 
The present invention also provides novel 3-selena-7-
azabicyclo[3.3.l]nonane compounds having the for-
mula: 
(2) 
where Ar is: 
-0-0-cn,-Q 
-cn,-OoCH,. -cn,-0-oCH, 
or \__{ 
OC:H3 
The invention further provides the hydroperchlorate, 
HCI, HBr and HI salts of the novel nonane compounds 
(2) and correspond salts of the 9-diol and 9-dimethoxy 
derivatives of the selena nonanes and methyl phenyl-
amine nonanes characterized by the formula: 
~ H I+ y N\ x-Ar (3) y 
where Ar is: 
-0-0-CH,-Q 
.. 
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-continued -continued 
Ar H x-
1 I+ 
(9) 
-CH,-OOCH; -cH,-Q-f OCH3 S 
or 
y~: 
y OCH3 
Z is Se, Sor 
Y=-H, -OH or -OCH3 and X is ClOc, CI-, 
Br-or I-. 
10 where Ar is Ph (i.e., 
15 -Q,.-(J 
CH2Ph,p-H3C6H4CH2, 3,4-(H3C0)2C6H2CH2, o-
ClC6H4, orp-CIC6H4; X-is CI04-, CI-, Br-, or I-; Z 
20 is Se, S, 0, or NCH2Ph; and Y is H, OH, or OCH3. 
In a similar manner the invention provides the 6,8-
diaryl substituted, selenium and nitrogen 3,7-
diheterabicyclo[3.3. l]nonanes including the 9-one, 9-
diol and 9-dimethoxy derivatives as well as the corre- 25 
sponding acid salts characterized by the formulae: 
The invention still further provides for related 
polyheterotricyclo compounds and corresponding de-
rivatives thereof characterized by the formulae: 
(10) 
0 
Ar 
I 
~: 
Ar 
I 
~~z 
y 
Ar 
I 
,Jc> 
y 
H Ar 
X I I I 
~)?:;z 
y 
(4) 
(5) 
(6) 
(7) 
30 
35 
40 
45 
r-Ar 
I x-
Ar H ~x-N+-H 
~t+ 
z j,,,, 0 :--...,.,-
OR 
Ar o Ar 
\'\N~I l-"7 
N N 
' ~ Ar Ar 
z 
(11) 
(12) 
where Ar is Ph, CH2Ph, o-H3CC0H4, p-H3CC6H4, o-
H3COC0H4,p-H3COC0H4, o-CICoH4, or p-CIC6H4; 
X-is CJ04-, Cl-, Br-, or I-; Z is Se, S, O, CHR or 
SO NR'; R is CH3, C2Hs, n-C3H7or i-C3H7; and R' is H, 
CH3, C2Hs or C(CH3)3. 
More specifically the invention relates to the 3-
selena-7-azabicyclo[3.3. l]nonane compounds and their 
respective hydroperchlorate salts as used in an antiar-
55 
rhythmic process. 
(8) 60 
Thus, it is an object of the present invention to pro-
vide novel compositions that display biological activity. 
Fulfillment of this object and the presence and fulfill-
ment of other objects will be apparent upon complete 
reading of the specification and claims. 
65 
DESCRIPTION OF THE PREFERRED 
EMBODIMENTS 
The chemical compositions according to the pre-
ferred embodiments of the present invention are 
heteronuclear ring organic compounds based on the 
3, 7-diheterabicyclo[3.3. l ]nonane structure as follows: 
.. 
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2 
z '1· ~, 
~ Ar 
0 6 
(13) 
5 
10 
(14) 
15 (15) 
20 
(16) 
25 
Wherein the 3-position of the 9-one structure for 
formula (13) is selenium, but includes oxygen, nitrogen 
as well as selenium in the other formulae (14), (15) and 30. 
(16) and also sulfur in the 9-disubstituted of formula 
(16). The 7-position is an alkylated nitrogen atom (aryl 
substituted tertiary amine) and includes the acid amine 
salts •such as the perchlorate and halogen acid salts, 
preferably the hydroperchlorate salt. The disubstituted 35 
9-position of the formula (16) is preferably either a 9-
diol or 9-dialkyloxy structure. 
The novel chemical compositions according to the 
preferred embodiments of the present invention also 40 include the 6,8-diaryl substituted 3,7-diheterabicy-
clo[3.3. l ]nonane structures as follows: 
,Ar 
HN 
~z 
0 
,Ar 
~: 
0 
HN 
Ar 
I 
v~z 
y 
(4) 
45 
50 
(5) 
55 
(6) 60 
65 
-continued 
Ar YK 
y 
x-
Ar H 
, I+ x-
v~: 
y 
(7) 
(8) 
(9) 
In these 6,8-diaryl substituted derivatives, the 3-posi-
tion is preferably selenium, sulfur, nitrogen, oxygen and 
carbon and includes the endo-endo and endo-exo iso-
mers. As in the previous formulae (13) through (16), the 
9-position can be preferably unsubstituted, 9-one, 9-diol 
or 9,9-dimethoxy and also includes the alkylated nitro-
gen atom at the 7-position and their corresponding ter-
tiary amine acid salts (hydroperchlorate, HCl, HBr and 
HI). 
The novel chemical compositions according to the 
preferred embodiments of the present invention further 
includes the related polyheteratricyclo compounds 
based on the following structural formulae: 
(10) 
(11) 
(12) 
In these tricycle compounds, the hereto atoms in-
clude selenium, sulfur, oxygen and nitrogen along with 
either two or four alkylated nitrogen atoms as well as a 
7 
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tertiary amine acid salts (preferably the hydroperchlo-
rate). 
These compounds are the active ingredients for po-
tential drugs and/or intermediates for the active ingre-
dients of potential drugs for use in the treatment of 5 
disorders of the heart. They display good antiarrhyth-
mic activity and as such are viable candidates to control 
arrhythmias in humans who have suffered heart attacks 
or infarctions. 
Typically, the 9-one and the tricycle ether oxygen 10 
and ketone containing compounds are synthesized by 
the reaction of a tetrahydroheterapyranone in the pres-
ents of an aldehyde and amine or ammonium salt ac-
cording to a Mannich or Mannich-type reaction. For 15 
example, and as illustrated in the following reaction 
scheme A, 4-selenanone (17) is typically reacted with an 
amine such as benzylamine, 2-aminomethylthiophene, 
phenethylamine, p-methoxyphenethylamine, 3,4-dime-
thoxyphenethylamine and the like and paraformalde- 20 
hyde in the presence of glacial acetic acid and methanol 
to produce the 3-selena-7-azabicyclo[3.3. l ]nonane-
9-ones (18). The 9-one (18) is then either reduced with 
hydrazine hydrate in triethylene glycol/potassium hy-
droxide media and then reacted directly with perchloric 25 
acid in benzene yielding the hydroperchlorate of 3-
selena-7-azabicyclo[3.3. l]nonanes ( 19) or the corre-
sponding 9,9-diol derivatives (20) respectively. 
(2) 
REACTION SCHEME A 
(I) 
0 () "" 
Se 
Se~ (18) 
N\ 
/2 Ar 
0 
30 
35 
40 
45 
isolation, the isomer is converted sequentially to the 
corresponding 6,8-diaryl-3-selena-7-azabicyclo[3.3.1-
]nonane (23) using the reducing agent hydrazine hy-
drate followed by conversion to the secondary amine 
salt (24); i.e., hydroperchlorate in this embodiment. 
Ar 
I 
Se 
REACTION SCHEME B 
+ 
HkN-::-/ 
O (21) 
c10.-
Ar 
I 
HNk' 
Se 
(23) 
t HCI04/CoH6 
Ar 
T / 
HN~A< S< 
~(24) 
Reaction scheme C using 1-benzyl-4-piperidone (25) 
in a manner closely analogous to the previous reactions 
scheme A which used 4-selenanone as a reactant. As 
) H,NNH,.H~O 
EG/KOH HCI04/C0Ho 
) HCI04/C0Ho 
(3) (4) 
Se CI04 
50 illustrated, the aryl amine (again benzylamine) and para-
formaldehyde react in the presence of glacial acetic acid 
and methanol to produce the N,N'-dibenzyl-3,7-
diazabicyclo[3.3.l]nonan-9-one (26). This diazabicy-
He 
I 
HO N\ 
Ar 
(19) OH (20) 
In reaction scheme B, the tetrahydroheterapyranone 
is reacted with an aldehyde in absolute ethanol and 
ammonium acetate to produce a mixture of 6,8-aryl 
substituted 3, 7-diheterabicyclo(3.3. l ]nonan-9-one iso-
mers. As specifically illustrated in scheme B using 4-
selenanone (17) as the reactant, a mixture of 6,8-diaryl-
3-selena-7-azabicyclo(3.3.1 ]nonan-9-one isomers (21) 
and (?2) are synthesized. As further illustrated and after 
55 clo(3.3. l]nonan-9-one (26) is then converted to one of 
three derivatives by one of three separate reaction path-
ways. Using perchloric acid in benzene and 3A molecu-
lar sieve with methanol, the hydroperchlorate amine 
salt of the 9,9-dimethoxy derivative (27) is produced. 
60 The use of perchloric acid in an aqueous media pro-
duces the hydraperchlorate amine salt of the 9,9-dihy-
droxy derivative (28). And, in a manner analogous to 
the reaction scheme A, a sequential reduction using 
65 hydrazine hydrate in triethylene glycol and potassium 
hydroxide followed by perchloric acid in benzene pro-
duces the hydroperchlorate tertiary amine salt of the 
reduced form of the diazabicyclo[3.3. l]nonane (29). 
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REACTION SCHEME C 
In reaction scheme D, the l-benzyl-4-piperidone (25) 40 
of scheme C is reacted with an aromatic aldehyde (or-
tho-chlorobenzaldehyde in this specifically illustrated 
embodiment) with ammonium acetate and absolute eth-
anol in a manner similar to scheme B. An isomeric mix- 45 
ture of the 6,8-ortho-chlorobenzyl derivatives of 3,7-
diazabicyclo[3.3.l]nonan-9-one (30) and (31) are pro-
duced. As further illustrated and with isomeric isola-
tion, the 9-ones (30) and (31) are converted to the corre-
sponding 6,8-bi(ortho-chlorophenyl) diazabicy- 50 
clo[3.3. l ]nonane (32) and (33) by the reducing agent 
hydrazine hydrate. This in turn can be converted to the 
isomeric mixture of the corresponding tertiary amine 
acid salts; i.e., hydroperchlorate salts in this illustrate 
(34) and (35). 
REACTION SCHEME D 
0 
II 0(25) 
N 
Ph) 
55 
60 
65 
-continued 
REACTION SCHEME D 
+ 
+ 
(32) 
o-ClCoH4 
,-
"1) Hg-ClCoH4 I ClO4-
N~ + 
Ph 
(34) 
o-ClC6H4 
,- NH 
g-ClC6H4 
N\ 
Ph 
0 
(31) 
19-C!C~:4 
g-ClC6H4 
N\ 
Ph 
(33) 
1
Q-ClC6H4 /liNH Hg-ClCoH4 
ClO4-
N+ \ 
Ph 
(35) 
In the closely related reaction scheme E, the generic 
starting tetrahydroheterapyranone (36) is reacted with 
4,910,311 
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pounds according to the present invention, the prepara-
tion and isolation of purified, water soluble, biological-
ly-active tertiary and secondary amine salts thereof and 
the antiarryhythmic activity of the compositions the 
an amine (benzylamine as illustrated) and paraformalde-
hyde in glacial acetic acid and methanol. A resulting 
mixture of the dispiro[5.1.5.3]hexadecan-7-one (37) and 
the pyrido[3,4-e]-1,3-oxazine (38) are produced. As 
further suggested and after isolation the corresponding 
tertiary amine acid salts (the hydroperchlorate salt (39) 
in this illustrated embodiment) can be produced by the 
action of perchloric acid in benzene and isopropyl alco-
hol. 
5 following sequence of examples are presented. 
REACTION SCHEME 
0 
II 0(36) 
r-Ph 
Ph / 
l_ ~ RN ;o~z 
OCHJ 
HCI04/C1,H1, 
(H1ChCHOH 
N 
I PhCH2NH2/H2C=O t H3COOH/H3COH 
(37) 
+ 
1 Ph 
Ph H ~CI04-N 0 CI04-
\_ I "-N· H j,,- 0 ::-,...,,..,- Z (39) 
OCH1 
It should be appreciated that other tetrahy-
droheterapyranones, arylamines and aromatic alde-
hydes can readily be selected as reactants for the Man- 45 
nich or Mannich-type reactions being illustrated in the 
reaction schemes. Similarly, various appropriate reac-
tants can be employed in the selective oxidation or 
reduction at the 9-position as generally known in the 
art. The Mannich reaction is particularly useful in that, 50 
as previously indicated, it does not require complicated 
reaction conditions and reagents. However for purposes 
of the present invention, other methods of synthesis 
well known in the art should be considered equivalent. 
For example and for more detailed disclosure of various 55 
alternative methods of synthesis (including the Mannich 
reaction) and methods of synthesis of various subse-
quent derivatives, the previously mentioned Chemical 
Reviews article by Jeyaraman et al. is again cited and 
herein incorporated by reference for such purposes. 60 
Furthermore, according to the preferred embodiments 
of the present invention, the water solubility of the 
3, 7-hetrabicyclo[3.3. l]nonane compounds and related 
heteratricyclo compounds can be advantageously en-
hanced by formation of the corresponding tertiary 65 
amine salts and the like, prior to patient treatment. 
In order to further illustrate the formation of the 
3,7-diheterabicyclo[3.3. l]nonanes and related com-
EXAMPLE 1 
7-Benzyl-3-selena-7-azabicyclo[3.3. l]nonan-9-one ( 40) 
Benzylamine (0.67 g, 6.26 mmol) and glacial acetic 
acid (0.38 g, 6.33 mmol) were dissolved in dry methanol 
(30 mL). Paraformaldehyde (1.5 g, 50 mmol) was added 
and the resulting mixture was brought to reflux under 
an atmosphere of_ nitrogen. 4-Selenanone (1.00 g, 6.13 
mmol) was then added in one portion which quickly 
turned the solution yellow. Boiling was continued 
under nitrogen in the dark for 5 hours. The resulting 
deep red solution was then allowed to cool to room 
temperature and was stirred for an additional 18 hours. 
The methanol was evaporated (aspirator) and the 
orange residual oil was partitioned between ether (50 
mL) and water (50 mL). The ether layer was discarded 
and the aqueous layer was made basic with KOH (85%, 
1.2 g 18.2 mmol). This solution was extracted with ether 
(5 X 40 mL). The combined extracts were dried 
(K2CO3) and evaporated (aspirator) to give an oil 
which was digested on a steam bath with Skelly B (50 
mL). Evaporation gave a light yellow oil which solidi-
fied upon standing. This solid was recrystallized (95% 
ethanol) to give 7-benzyl-3-selena-7-azabicyclo[3.3. l-
]nonan-9-one (0.78 g, 43%) as white needles: mp 
91°-92° C.; IR (KBr) cm-11726 (C=O); IH NMR 
(DCCI}) 82.71 [m, 4 H, H(l,5), H(6,8)ax], 3.08 [m, 2 H, 
H(6.8)], 3.20 [m, 4 H, H(2,4)], 3.57 [s, 2 H, H(l 1-
13 
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EXAMPLE III 
7-Phenethyl-3-~elena-7-azabicyclo[3.3.1 ]nonan-9-one 
(42) 
A solution was made of phenethylamine (1.48 g, 12.3 
mmol) and glacial acetic acid (0.85 g, 14.2 mmol) in 
methanol (60 mL). Paraformaldehyde (3.0 g, 100 mmol) 
was added and the resulting mixture was heated to 
ArC!!2)], 7.32 [m, 5 H, ArH]; 13C NMR (DCCb) ppm 
25.5 [t, C(2,4)], 46.2 [d, C(l,5)], 59.0 [t, C(6,8)], 61.5[t, 
C(ll-ArCH2)], 127.1 [d, C(4')], 128.2 (d) and 128.6 (d) 
[C(2',3',~6')], 138.0 [s, C(l')], 213.8 [s, C(9)]; 15N NMR 5 (DCCl3) ppm 38.31 [N(7)]; 77 Se NMR (DCCb) ppm 
84.68 [Se(3)]. A satisfactory elemental analysis proved 
very difficult for the compound and thus it was con-
verted to the hydroperchlorate salt without further 
purification. 10 reflux with magnetic stirring under an atmosphere of 
nitrogen. 4-Selenanone (2.00 g, 12.3 mmol) was added 
and boiling was continued for 5 hours resulting in an 
orange solution. Methanol was evaporated (aspirator) 
and the residual orange oil was mixed with water (200 
(40) 
15 mL). This aqueous mixture was made basic by addition 
of NaOH (2.0 g, SO mmol) and was then extracted with 
ether (5 X 40 mL). The combined extracts were washed 
with saturated brine and dried (K2CO3). Evaporation 
(aspirator) gave a brown residue which was digested in 
EXAMPLE II 
7-(2-Thiophene)methyl-3-selena-7-azabicyclo[3.3. l]no-
nan-9-one (41) 
20 boiling Skelly B (150) mL). Evaporation of Skelly B 
(150 mL). Evaporation of the Skelly B gave a solid 
which was recrystallized (ethanol) to give 0.82 g (22%) 
of 7-phenethyl-3-selena-7-azabicyclo[3.3. l]nonan-9-one 
A solution was made of 2-aminomethylthiophene 25 
(1.39 g, 12.3 mmol) and glacial acetic acid (1.10 g, 18.3 
mmol) in methanol (60 mL) in a 150 mL, three-necked, 
round-bottomed flask equipped with a water-cooled 
condenser. To this solution was added paraformalde- 30 
hyde (3.0 g, 100 mmol) and the resulting mixture was 
heated to reflux. 4-Selenanone (2.00 g, 12.3 mmol) was 
added and reflux was continued for S hours. After al-
lowing the resulting red solution to cool to room tem-
perature, the methanol was evaporated (aspirator) to 35 
give a red oil. This oil was partitioned between water 
and ether (100 mL:30 mL). The ether portion was dis-
carded and the aqueous layer was made basic by the 
addition of NaOH (1.5 g, 37.5 mmol). The resulting 40 
yellow suspension was extracted with ether (5 X 40 
mL). The combined extracts were washed with water 
(2 X 30 mL) and dried (K2CO3). Evaporation of the 
ether gave a brown oil which was digested in boiling 
Skelly. B (3 X 100 mL). Evaporation of the Skelly B 45 
gave 1.72 g of 7-benzyl-3-selena-7-azabicyclo[3.3.l]no-
nan-9-one as a colorless viscous oil (47%): IR (film) 
cm- 1 1710 (C=O); 1H NMR (CDCl3) 62.60-2.74 [m, 4 
H, H(2,4)], 3.02-3.18 [m, 4 H, H(l,S), H(6,8)ax], 3.27 50 
[c;ld, 2 H, H(6,8)eq, J = 11.7 Hz, 3.4 Hz], 3.75 [s, 2 H, 
H(lO)], 6.0-7.30 [m, 3 H, ArH]; 13C NMR (CDCl3) ppm 
24.8 [C(2,4)], 46.0 [C(l,5)], 55.6 [C(lO)], 58.5 [C(6,8)], 
124.9 [C(4')], 125.5 [C(2')], 126.1 [C(3')], 141.4 [C(l')], 
212.9 [C(9)]; 15N NMR (CDCl3) ppm 40.31 [N(7)]; 77Se 55 
NMR (CDCl3) ppm 86.28 [Se(3)]. The compound was 
used without further purification. 
(41) 60 
as a light tan solid: mp 91°-92° C.; IR (KBr) cm-11710 
(C=O); IH NMR (DCCb 62.62-283 [m, 8 H, 
H(2,4,l,S,10-ArCH2)], 3.02-3.20 [m, 6 H, H(6,8,ll-
NCH2)], 7.16-7.38[m, SH, Ar-H]; 13C NMR (DCCl3) 
ppm-25.4 [5, C(2,4)], 33.7 [5, C(lO-ArCH2)], 46.2 [d, 
C(l,5)], 58.3 [S, C(ll-NCH2)], 59.1 [t, C(6,8)], 125.9 [s, 
C(4')], 128.1 [d, C(2',6') or C(3',5')], 128.4 [d, C(3',5') or 
C(2',6')], 139.7 [s, C(l')], 213.5 [s, C(9)]; ISN NMR 
(DCCb) ppm 35.44 [N(7)]; 77Se NMR (DCCb) ppm 
79.51 [Se(3)]. The compound was converted to the 
hydroperchlorate salt without further purification. 
(42) 
EXAMPLE IV 
7-p-Methoxyphenethyl-3-selena-7-azabicyclo[3.3. l ]no-
nan-9-one (43) 
A solution was made of p-methoxyphenethylamine 
(0.93 g, 6.16 mmol) and glacial acetic acid (0.50 g, 8.33 
mmol) in methanol (40 mL). Paraformaldehyde (1.50 g, 
50.0 mmol) was added and the resulting mixture was 
heated to reflux under an atmosphere of nitrogen. 4-
Selenanone 10 (1.00 g, 613 mmol) was added in one 
portion and boiling was continued for 4 hours. The 
methanol was evaporated (aspirator) from the resulting 
orange solution to give a very viscous red oil. This oil 
was dissolved in water (150 mL) and KOH (85%, 1.0 g, 
I 5.2 mmol) was added to make the solution very basic. 
The resulting yellow suspension was extracted with 
ether (5 X 40 mL). The combined extracts were washed 
with water 930 mL) and dried (K2CO3). Evaporation of 
the ether (aspirator) gave 0.72 g (35%) 7-p-methoxy-
phenethyl-3-selena-7-azabicyclo[3.3.l]nonan-9-one as a 
65 light ye!low oil: IR (neat) cm-1 1723 (C=O); lff NMR 
(DCCl3) 62.50-2.80 [m, 8 H, H(l,5,2,4,10-ArCH2)], 
2.96-3.14 [m, 6 H, H(6,8,ll,NCH2)], 3.71 [s, 3H, 
OCH3], 6.72-6.90 [m, 2 H, H(3',5')T,'7.00-7.16 [m, 2 H, 
.. 
4,910,311 
16 15 
an oil bath under a nitrogen atmosphere for 12 hours. 
After cooling to room temperature, the solution was 
poµred into water (200 mL) and the resulting suspen-
sion was extracted with ether (5 X 40 mL). The corn-
H(2',6')]; 13C NMR (DCCl3) ppm 24.6 [C(2,4)], 32.0 
[C(lO-ArCH2)], 45.4 [C(l,5)], 54.2 [OCH3], 57.8 [C(l l-
NCH2)], 58.2 [C(6,8)], 112.8 [C(3',5')], 128.5 [C(2',6')], 
130.9 [C(l')], 156.9 [C(4')], 212.5 [C(9)]; 15N NMR 
(DCCl3) ppm 35.43 [N(7)]; 77Se NMR (DCCl3) [Se(3)] 
ppm 78.81. Without further purification the compound 
was converted to the hydroperchlorate salt. 
(43) 
s bined extracts were dried overnight (K2CO3) and 
cooled to 0' C. Perchloric acid (60%, 2.0 g, 11.9 mmol) 
was added dropwise. The yellow orange solid which 
formed was filtered and recrystallized (methanol) to 
give 7-benzyl-3-selena-7-azabicyclo[3.3. l]nonane hy-
10 droperchlorate (1.94 g, 75%) as white needles: mp 
161.0'-162.0' C. (dee); IR (KBr) cm-I 3440, 1105; IH 
NMR (DMSOd6) ol.75 [d, 1 H, H(9), 1 = 13.7 Hz], 1.88 
[d, 1 H, H(9), 1 = 13.6 Hz], 2.41 [br s, 2 H, H(l,5)], 2.64 
[d, 2H, H(2,4)ax, 1 = 12.21 Hz], 3.19 [d, 2 H, H(2,4)eq, 
15 1 = 12.10 Hz], 3.42 [m, 2 H, H(6,8)ax], 3.61 [d, 2H, 
H(6,8)eq, 1 = 11.83 Hz], 4.32 [d, 2 H, H(l0-NC!!2), 
1=5.75 Hz]; 13C NMR (DMSO-d6) ppm 22.0 [C(2,4)], 
25.2 [C(l,5)], 28.5 [C(9)], 56.6 [C(6,8)], 60.5 [C(l0-N-
CH2)], 128.9, 129.3, 129.8, 130.0 [Are]; 15N NMR 
EXAMPLE V 
7-(3,4-Dimethoxy )phenethyl-3-selena-7-azabicy-
clo[3. 3. l]nonan-9-one (44) 20 (DMSO-d6) ppm 51.56 [N(7)]; 77Se NMR (DMSO-d6) 
ppm 96.61 [Se(3)]. Analysis calculated for 
C14H20CINO4Se: C, 44.14; H, 5.30; N, 3.68; Cl, 9.32; Se, 
20.75. Found: C, 44.45; H, 5.38; N, 3.61; Cl, 9.52; Se, 
20.67. 
A solution was made of 3,4-dimethoxyphenethyla-
mine (2.23 g, 12.3 mmol) and glacial acetic acid (1.0 g, 
16.6 mmol) in methanol (60 mL). Paraformaldehyde 
(3.0 g, 100 mmol) was added and the resulting mixture 25 
was heated to boiling. 4-Selenanone (2.00 g, 12.3 mmol) 
was added and boiling was continued for 4 hours. The 
resulting brown solution was evaporated (aspirator) to a 
brown oil. This oil was added to water (150 mL) and the 
mixture which formed was extracted with ether ( 4 X 50 30 
mL). The combined extracts were washed with water 
(30 mL) and dried (K2CO3). Evaporation (aspirator) 
gave a dark brown oil which was digested in boiling 
Skelly 8 (3 X 100 mL). After decantation from a small 
amount of residual oil, evaporation of the supernatant 35 gave 1.4 g of 7-(3,4-dimethoxy)phenethyl-3-selena-7-
azabicyclo[3.3. l]nonan-9-one as a pale yellow viscous 
oil (31%): IR (neat) cm- 1 1730 (C=O); 1H NMR 
(DCCl3) 82.60-2.80 [m, 8 H, H(2,4, 1,5, lO-ArCH2)], 
3.00-3.20 [m, 6 H, H(6,8, 11-NC!!z)]; 3.80 [s, 3 H, 40 OCH3], 3.84 [s, 3 H, OCH3], 7.70-7.90 [m, 3 H, ArH]; 
13C NMR (DCCl3) ppm 25.4 [C(2,4)], 33.2 [C(lO-
ArCH2)], 46.2 [C(l,5)], 55.7 [both OCH3], 58.6 [C(l l-
NCH2)], 59.1 [C(6,8)], 111.3, 112.0, 120.5, 132.8 [C(l')], 
141.2, 148.7, 213.8 [C(9)]; 15N NMR (DCCl3) ppm 35.16 45 [N(7)); 77Se NMR (DCCl3) ppm 77.00 [Se(3)]. Without 
further purification, the compound was converted to 
the hydroperchlorate salt. 
(44) 50 
(45) 
EXAMPLE VII 
7-(2-Thiophene )meth y 1-3-selena-7-azabicyclo [3. 3 .1 ]no-
nane Hydroperchlorate (46) 
7-(2-Thiophene)methyl-3-selena-7-azabicyclo[3.3. l-
]nonane hydroperchlorate (1.0 g, 3.33 mmol) and anhy-
drous hydrazine (95%, 2.0 g, 5.94 mmol) were dissolved 
in triethylene glycol (40 mL) in a 60 mL, jacketed flask 
which was equipped for distillation. Potassium hydrox-
ide (85%, 3.0 g, 45.5 mmol) was added and the resulting 
mixture was heated with stirring to 140'-145' C. by 
boiling xylene in the jacket of the reaction vessel. Heat-
ing was continued for 4 hours after which time the 
reaction mixture was cooled to room temperature and 
was poured into cool water £150 mL). The resulting 
suspension was extracted with ether (5 X 40 mL) and the 
combined extracts were dried (K2CO3). After filtration 
of the desiccant, 60% HClO4 (1.0 g, 6.0 mmol) was 
added dropwise, very slowly, causing an orange solid to 
form. The ether was decanted and the solid was recrys-
tallized twice (isopropyl alcohol, decolorizing carbon) 
to give 0.88 g of 7-(2-Thiophene)methyl-3-selena-7-
OCH3 
55 azabicyclo[3.3. l]nonane hydroperchlorate as white nee-
dles (68%): mp 141.0'-141.5' C.: IR (KBr) cm- 1 3450, 
1150; 1H NMR (DMSO-d6) ol.74 [d, 1 H, H(9), 1 = 13.6 
Hz], 1.86 [d, 1 H, H(9), 1 = 13.6 Hz], 2.43 [br s, 2 H, 
H(l,5)], 2.64 [d, 2 H, H(2.4)ax, 1 = 12.0 Hz], 3.19 [d, 2 H, 
EXAMPLE VI 
7-Benzyl-3-selena-7-azabicyclo[3.3. l]nonane 
Hydroperchlorate ( 45) 
60 H(2,4)eq, 1 = 11.3 Hz], 3.35 [m, 2 H, H(6,8)ax], 3.62 [d, 2 
H, H(6,8)eq, 1 = 12.7 Hz], 4.53 [d, 12 H, H(I0-NC!!2), 
1=5.3 Hz], 7.16 [dd, 1 H, H(3'), 1=5.1 Hz, 3.7 Hz], 7.36 
[d, 1 H, H(2'), 1=3.3 Hz], 7.75 [d, 1 H, H(4'), 1=5.1 
A solution was made of 7-benzyl-3-selena-7-azabicy-
clo[3.3. l]nonan-9-one (2.0 g, 6.8 mmol) and hydrazine 65 
(95%, 5.0 g, 148 mmol) in triethylene glycol (40 mL). 
Potassium hydroxide (85%, 10.0 g, 152 mmol) was 
added and the resulting mixture was heated to 140' C. in 
Hz], 9.24 [br s, 1 H, H(7)]; IJC NMR (DMSO-d6) ppm 
21.9 [t, C(2,4)], 25.3 [d, C(l,5)], 28.6 [t, C(9)], 60.5 [t, 
C(I0-NCH2)], 56.2 (t, C(6,8)], 127.2 [d, C(4')], 129.3 [d, 
C(2')], 130.5 [s, C(l')], 131.8 [d, C(3')]; 15N NMR 
(DMSO-d6) ppm 58.54 [N(7)]; 77Se NMR (DMSO-d6) 
., 
17 
4,910,311 
18 
ppm 89.41 [Se(3)]. Analysis calculated for 
C12H1sClNO4Se: C, 37.27; H, 4.69; N, 3.62; Se, 20.42. 
Found: C, 37.30; H, 4.76; N, 3.60; Se, 20.10. 
(46) 5 
mmol), hydrazine (95%, 1.00 g, 29.7 mmol), and potas-
sium hydroxide (85%, 3.0 g, 45.S mmol) in triethylene 
glycol (25 mL). Under a rapid stream of nitrogen, the 
suspension was heated to 140° -145° C. by boiling xylene 
in the jacket of the flask. Stirring was continued at this 
temperature for 3 hours during which time a small 
amount of water and excess hydrazine distilled from the 
reaction mixture. After cooling to room temperature, 
the resulting solution was diluted with water (100 mL) 
EXAMPLE VIII 
7-Phenethyl-3-selena-7-azabicyclo[3.3. l]nonane 
Hydroperchlorate (47) 
10 and was extracted with ether (S X 40 mL). The com-
bined ether extracts were dried (K2CO3) overnight and 
60% perchloric acid (O.S g, 3.0 mmol) was added very 
slowly. This precipitated an orange solid. The ether was 
decanted and the solid was recrystallized (absolute etha-
A jacketed flask was charged with a mixture of 7-
phenethyl-3-selena-7-azabicyclo[3.3.1 ]nonan-9-one (1.3 
15 nol) with the aid of decolorizing carbon to give 0.58 g 
(71 % ) of 7-p-methoxyphenethyl-3-selena-7-azabicy-
clo[3.3. l]nonane hydroperchlorate as white needles: mp 
208.5°-209.0° C.; IR (KBr) cm- 1 3425, 1085; IH NMR 
g, 4.2 mmol) N2H4 (95%, 2.0 g, 59 mmol), and KOH 
(85%, 6,0 g, 91 mmol) in triethylene glycol (40 mL). 20 
The flask was equipped for simple distillation under a 
rapid stream of nitrogen. The reaction mixture was 
heated to 140° -145° C. by boiling xylene contained in 
the jacket. Heating was continued under a nitrogen 
stream for S hours. During this time, a small amount of 25 
water and hydrazine distilled out. The resulting clear, 
light brown solution was cooled in a water bath to room 
temperature and was then poured into ice-water (200 
mL). The white suspension which formed was ex-
tracted with ether (S X 40 mL). The combined ether 30 
extracts were washed with brine (30 mL) and dried 
(K2CO3) overnight. After filtering out the desiccant, 
this ether solution was cooled to 0° -5° C. in an ice bath 
and 60% HClQ4(l.0 g, 6.0 mmol) was added dropwise, 
very slowly. After stirring overnight, the resulting 35 
orange precipitate was filtered and recrystallized (meth-
anol, decolorizing carbon) to give 0.67 g (40%) of 7-
phenethyl-3-selena-7-azabicyclo[3.3. 1 ]nonane hy-
droperchlorate as white plates: mp 249° -250° C. (dee): 
IR (KBr) cm- 1 3400, 1140; 1H NMR (DMSO-d6) 81.73 40 
[br d, 1 H, H(9), 1 = 14.0 Hz], 1.89 [br d, 1 H, H(9), 
1 = 13.8 Hz], 2.41 [br s, 2 H, H(l,S)], 2.64 [d, 2 H, 
H(2,4)ax, 1 = 12. l Hz], 3.07 [t, 2 H, H(l l-ArCH2), 1 = 7.9 
Hz], 3.20 [d, 2 H, H(2.4)eq, J = 12.2 Hz], 3.33 [m, 4 H, 
H(l0-NCH2), (6,8)axl, 3.86 [d, 2 H, H(6,8)eq, 1 = 12.3 45 
Hz], 7.28.::'7.50 [m, 5 H, Ar-HJ, 8.89 [br s, 1 H, H(7)]; 13C 
NMR (DMSO-d6) ppm 21.9 [t, C(2,4)], 25.3 [d, C(l,S)], 
28.S [t, C(9) or C(l l-ArCH2)], 29.9 [t, C(l l-ArCH2) or 
C(9)], 56.7 [y, C(6,8)], 58.8 [t, C(l0-NCH2)], 126.8 [d, 
C(4')], 128.S [d, C(2',6',3',S')], 136.2 °[s, C(l'))]; 15N 50 
NMR (DMSO-d6) ppm 48.25 [N(7)]; 77Se NMR 
(DMSO-d6) ppm 88.42 [Se(3)]. Analysis calculated for 
C1sH22ClNO4Se: C, 45.64; H, 5.62; N, 3.55; Se, 20.00. 
Found C, 45.77; H, 5.80; N, 3.48; Se, 19.85. 
(DMSO-d6) 81.73 [br d, 1 H, H(9), 1 = 14 Hz], 1.90 [br d, 
1 H, H(9), 1 = 14 Hz], 2.42 [br s, 2 H, H(l,S)], 2.65 [d, 2 
H, H(2,4)ax, 1 = 12 Hz], 3.02 [t, 2 H, H(l l-ArCH2) 1 = 7 
Hz], 3.22 [d, 2 H, H(2,4), 1 = 14 Hz], 3.30 [m, 2H, H(l0-
NCH2)], 3.36 [d, 2 H, H(6,8)ax, 1 = 12 Hz], 3.76 [s, 3 H, 
OCH3], 3.86 [d, 2 H, H(6,8)eq, 1 = 12 Hz], 6.97 [d, 2 H, 
H(3',S'), 1=9 Hz], 7.32 [d, 2 H, H(2',6'), 1=9 Hz], 8.92 
[br s, 1 H, H(7)]; 13C NMR (DMSO-d6) ppm 21.9 [t, 
C(2,4)], 25.3 [d, C(l,5)], 28.5 [t, C(9) or C(l 1)], 28.9 [t, 
C(l l-ArCH2) or C(9)], 55.0 [q, OCH3], 56.7 [t, C(6,8)], 
58.9 [t, C(l0-NCH2)], 114.0 [d, C(3',S')], 127.7 [s, C(l')], 
129.6 [d, C(2',6)], 158.1 [s, C(4')]; 15N NMR (DMSO-
d6) ppm 48.10 [N(7)]; 77Se NMR (DMSO-d6) ppm 88.64 
[Se(3)]. Analysis calculated for C16H24ClNO5Se: C, 
45.24; H, 5.69; N, 3.30; Se, 18.59. Found: C, 45.42; H, 
5.80; N, 3.30; Se, 18.46. 
EXAMPLEX 
7-(3,4-Dimethoxy )phenethy-3-selena-7-azabicy-
clo[3.3. l ]nonane Hydroperchlorate (49) 
(48) 
A jacketed flask which was equipped for distillation, 
was charged with solution of 7-(3,4-dimethoxy)-
phenethyl-3-selena-7-azabicyclo[3.3. l ]nonan-9-one 
(1.10 g, 3.00 mmol), anhydrous hydrazine (95%, 200 g, 
5.94 mmol), and potassium hydroxide (85%, 3.0 g, 45.S 
mmol) in triethylene glycol (40 mL). This solution was 
heated to 140° -145° C. by boiling xylene in the jacket of 
the reaction flask. Heating was continued for 4 hours 
(47) 
55 during which time a small amount of water and excess 
hydrazine distilled. The reaction mixture, which had 
turned brown, was cooled and poured into cool water 
(ISO mL). The resulting suspension was extracted with 
ether (4XS0 mL). The combined extracts were washed 
EXAMPLE IX 
7-p-Methoxyphenethyl-3-selena-7-azabicyclo[3.3.1 ]no-
nane Hydroperchlorate (48) 
A jacketed flask equipped for simple distillation was 
charged with a suspension of 7-p-methoxyphenethyl-3-
selena-7-azabicyclo[3.3. l]nonan-9-one (0.65 g, 1.92 
60 with water (40 mL) and dried (K2CO3). Perchloric acid 
(60%, 1.0 g, 6.0 mmol) was added to the ether solution 
dropwise, very slowly. This precipitated a white solid 
which rapidly turned orange. The ether was decanted 
and the solid was recrystallized twice from absolute 
65 ethanol (decolorizing carbon) to give 0.92 g (68%) of 
7-(3,4-dimethoxy)phenethy-3-selena-7-azabicyclo[3.3. l-
]nonane hydroperchlorate as a white crystalline solid: 
mp 162°-163° C.; IR (KBr) cm- 1 3450, 1090, 1H NMR 
19 
4,910,311 
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(DMSO-d6) ol.74 [d, lH, H(9), J=13 Hz], 1.92 [d, 1 H, 
H(9), J = 13 Hz], 2.42 [br s, 2 H, H(l,5)], 2.65 (d, 2 H, 
H(2,4)ax, J = 12 Hz], 3.02 [t, 2 H, H(l l-ArCH2)], 3.22 [d, 
2 H, H(2,4)eq, J = 12 Hz], 3.36 [m, 4 H, H(l0-:-NCH2) and 
H(6,8)ax], 3.76 [s, 3H, OCH3], 3.80 [x, 3 H, OCH3], 3.87 5 
[d, 2 H, H(6,8)eq, J = 12 Hz], 6.88-7.02 [m, 3 H, ArH], 
8.88 [br s, 1 H, H(7)]; 13C NMR (DMSO-d6) ppm 22.0 
[C(2,4)], 25.3 [C(l,5)], 28.5 [C(l 1) or C(9)], 29.4 [C(9) or 
C(l 1) ArCH2)], 55.4 [OCH3], 56.7 [C(6,8)], 58.9 [C(l0)-
NCH2)], fi2.0, 112.3, 120.6, 128.3 [C(l')], 147.7 [C(3') or 10 
C(4')], 148.8 [C(3') or C(4')], 15N NMR (DMSO-d6) 
ppm 48.03 [N(7)]; 77Se NMR (DMSO-d6) ppm 88.35 
[Se(3)]. Analysis calculated for C17H26ClNO6Se: C, 
44.90; H, 5.76; N, 3.08. Found: C, 44.86; H, 5.86; N, 3.04. 
about 30°-40° C., ether (15 mL) was added and stirring 
was continued for 10 minutes. Cooling (5° C.) overnight 
resulted in the formation of a yellow solid which was 
filtered and recrystallized (ethanol) to give 0.89 g (17%) 
of 6,8-diphenyl-3-selena-7-azabicyclo[3.3. l]nonan-9-one 
as white needles: mp 207.0°-208.5° C. (dee); IR (KBr) 
cm- 1 3320 (N-H), 1730 (C=O); IN NMR (DCCl3) 
o 1. 77 [br s, 1 H, H(7)], 2.84 [br d, 4 H, H(2,4), J = 8 Hz], 
3.59 [m, 2 H, H(l,5)], 5.04 [m, 2 H, H(6,8)], 7.20-7.50 [m, 
10 H,ArH]; 13C NMR (DCCl3) ppm 92.2 [C(2,4)], 54.0 
(49) 
[C(l,5)], 64.2 [C(6,8)], 144.4 [C(l'), 127.0 [C(3',5') or 
C(2',6')], 127.9 [C(4')], 128.7 [C(2',6') or C(3',5)], 207.2 
[C(9)]; 15N NMR (DCCl3) ppm 63.28 [N(7)]; 77Se NMR 
15 (DCCl3) ppm 25.38 [Se(3)]. Analysis calculated ~or 
C19H19NOSe: C, 64.04; H, 5.38; N, 3.93; Se, 22.17. 
Found: C, 63.86; H, 5.45; N, 3.81; Se, 21.90. 
EXAMPLE XI 
7-Benzyl-3-selena-7-azabicyclo[3.3. l ]nonan-9,9-diol 
Hydroperchlorate (50) 
7-Benzyl-3-selena-7-azabicyclo[3.3. l]nonan-9-one 
20 
25 
(0.65 g, 2.2 mmol) was dissolved in dry benzene (250 30 
mL). Perchloric acid (60%, 1.0 g, 6.0 mmol) was added 
dropwise very slowly with cooling and swirling. This 
precipitated an orange solid which adhered to the side 
of the flask. The benzene was decanted and the solid 
was recrystallized (95% ethanol) to give 7-benzyl-3- 35 
selena-7-azabicyclo(3.3. l]nonan-9,9-diol hydroperchlo-
rate (0.62 g, 68.3%) as white needles: mp 214.0°-216.0° 
C. (dee); IR (KBr) cm- 1 3430, 1080; 1H NMR (DMSO-
d6) 02.43 [br s, 2 H, H(2,4)axl, 2.72 [br d, 2 H, H(2.4)eq], 
3.22-3.50 [m, 6 H, H(6,8)ax, H(l,5), OH], 3.50-3.64 [m, 40 
2 H, H(6,8)eq], 4.35 [d, 2 H, H(10-NCH2}], 7.40-7.70 [m, 
5 H, ArH], 9.20 [br s, 1 H, H(7)]; 13CNMR (DMSO-d6) 
ppm 21.1 [C(2,4)], 34.7 [C(l,5)], 54.9 (C(6,8)], 60.1 
(C(l0)-NCH2)], 92.5 (C(9)], 129.2, 129.7, 130.0, 130.5 
[ArC]; 15"& NMR (DMSO-d6) ppm 51.88 [N(7)]; 77Se 45 
NMR (DMSO-d6) ppm 62.39 [Se(3)]. Analysis calcu-
lated for C14H20NC1SeO6: N, 3.39; Se, 19.13. Found: N, 
3.20; Se, 19.51. 
A e ~+ CI04 -HO \_Ph (50) 50 
Ph 
I 
HN tPh 
~Se 
0~ 
(51) 
EXAMPLE XIII 
6,8-Di(2-thiophene)-3-selena-7-azabicyclo(3.3.1 ]nonan-
9-one (52) 
A solution of 2-thiophenecarboxaldehyde (1.38 g, 
12.3 mmol) and dry ammonium acetate (0.94 g, 12.3 
mmol) in absolute ethanol (20 mL) was heated to boil-
ing on a hot plate. To this was added a hot solution of 
freshly sublimed 4-selenanone 10 (1.00 g, 6.13 mmol) in 
absolute ethanol (15 mL). Boiling was continued for 10 
minutes with ethanol being added to keep the volume 
constant. During this time the colorless solution turned 
yellow. The flask was removed from the hot plate, was 
stoppered, and was allowed to stand at room tempera-
ture for 3 days. The resulting dark red solution was 
decanted from the yellow solid which had formed dur-
ing this time. The solid was taken up in benzene (100 
mL) and was treated with decolorized carbon. Filtra-
tion followed by evaporation (aspirator) gave a light 
brown solid which was recrystallized (methanol) to 
give 0.40 g, (18%) of 6,8-Di(2-thiophene)-3-selena-7-
azabicyclo(3.3.l]nonan-9-one as a light yellow solid: mp 
155°-161° C. (dee); IR (KBr) cm-I 3260 (N-H), 1723 
(C=O); 1H NMR (DCCl3) o2. 16 [br s, 1 H, H(7)], 2.80 
[m, 4 H, H(l,5) and H(2,4)ax], 3.57 [d, 2 H, H(2,4)eq, 
OH 
EXAMPLE XII 
6,8-Diphenyl-3-selena-7-azabicyclo(3.3.1 ]nonan-9-one 
(51) 
55 J = 10.03 Hz], 5.32 [d, 2 H, H(6,8), J =3.96 Hz], 
6.90-7.40 [m, 6 H, Ar-H]; 13C NMR (DCCl3) ppm 29.3 
[C(2,4)], 54.6 (C(l,5)], 59.1 (C(6,8)], 123.7, 124.8, 126.3 
[C(2',3',4')], 147.0 [C(l')], 213.3 [C(9)]; 15N NMR 
(DCCl3) ppm 67.09 (N(7)]; 77Se NMR (DCCIJ) ppm 
60 30.60 (Se(3)]. 
A jacketed flask was charged with a solution of dry 
ammonium acetate (2.31 g, 30.0 mmol) in absolute etha-
nol (30 mL) which was warmed to 65° C. by boiling 
methanol in the jacket. A solution of 4-selenanone (2.45 
g, 15.0 mmol) and benzaldehyde (3.18 g, 30.0 mmol) in 65 
absolute ethanol (15 mL) was added in one portion. The 
resulting solution was stirred under nitrogen at 65° C. 
fClr 45 minutes. After cooling the reaction mixture to 
6,8-Di(2-thiophene )-3-selena-7-azabicyclo(3 .3. 1 ]no-
nan-9-one proved difficult to purify in order to obtain a 
satisfactory elemental analysis. Thus it was used di-
rectly in the conversion to the amine 6,8-di(2-thio-
phene)-3-selena-7-azabicyclo(3.3. l]nonane of Example 
XVI which did lend itself to purification and was ana-
lyzed. 
4,910,311 
22 21 
,) 
I 
I 
HN~ 
~Se 
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EXAMPLE XIV 
(52) 
6,8-Di( 4-chlorophenyl)-3-selena-7-azabicyclo[3.3. I ]no-
nan-9-one (the endo,exo isomer) (53),(54) 
5 
10 
15 
A solution of dry ammonium acetate (0.94 g, 12.3 
mmol) and p-chlorobenzaldehyde (1.73 g, 12.3 mmol) in 20 
absolute ethanol (20 mL) was heated to boiling in a 
50-mL, Erlenmeyer flask on a hot plate. To this solution 
was added a boiling solution of freshly sublimed 4-
selenanone (1.00 g, 6.13 mmol) in absolute ethanol (15 25 
mL). The combined solutions were boiled for 10 min 
with ethanol being added to keep the volume constant. 
During this time the colorless solution became light 
yellow. The flask was then removed from the hot plate 
and stoppered. The reaction mixture was allowed to 30 
stand at room temperature for 3 days, during which 
time the solution turned dark reddish-brown and a yel-
low solid formed. The liquid was decanted and the solid 
was dissolved in benzene (100 mL). This solution was 
treated with decolorizing carbon and was filtered. 35 
Evaporation (aspirator) of the benzene gave a light 
brown solid which was recrystallized (absolute ethanol) 
giving 0.33 g. ( 13%) of 6,8-di( 4-chlorophenyl)-3-selena-
7-azabicyclo[3.3. l]nonan-9-one (the endo,exo isomer) as 
a light tan solid: mp 219° -220° C. (dee); IR (KBr) cm- 1 40 
3280 (N-H), 1722 (C=O); 1H NMR (DCCl3) 81.70 [br 
s, 1 H, H(7)], 2.69 [m, 4 H, H(l,5) and H(2,4)ax], 3.56 [d, 
2 H, H(2,4)eq, J = 10.20 Hz], 4.99 [d, 2 H, H(6,8), J =4.07 
Hz], 7.30-7.40 [m, 8 H, Ar-H]; 13<:; NMR (DCCl3) ppm 
29.0 [C(2,4)], 53.0 [C(l,50], 63.4[C(6,8)], 128.2 [C(2',6') 45 
or C(3',5')], 128.8 [C(3',5') or C(2',6')], 133.7 [C(4')], 
142.5 [C(l')], 213.4 [C(9)]; 15N NMR (DCCIJ) ppm 
62.84 [N(7)]; 77Se NMR (DCCl3) ppm 26.67 [Se(3)]. 
6,8-Di( 4-chlorophenyl)-3-selena-7-azabicyclo[3.3. l- 50 ]nonan-9-one (the endo,exo isomer) proved very diffi-
cult to purify for elementary analysis. It was converted 
to amine 6,8-di(4-chorophenyl)-3-selena-7-azabicy-
clo[3.3. i]nonane. 
Addition of water (10 mL) to the original mother 55 
liquor caused the precipitation of a dense brown solid. 
After allowing this mixture to stand at room tempera-
ture overnight, the solid was filtered and recrystallized 
(ethanol, decolorizing carbon) to give 0.2 g (7%) of 
6,8-di( 4-chlorophenyl)-3-selena-7-azabicyclo[3.3. l ]no- 60 
nan-9,-one (the endo, endo isomer) as a light tan solid: 
mp !68°-171° C. (dee); IR (KBr) cm- 1 3315 (N-H), 
1710 (C=O); 1H NMR (CDCh) 82.68-2.90 [m, 2 H, 
H(2,4)ax], 2.83 [br s, 2 H, Hl,5)], 3.06-3.18 [m, 2 H, 
H(2,4)eq], 4.48 [br s, 2 H, H(6,8)], 7.30-7.60 [m, 8 H, 65 
ArH]; 13C NMR (CDCl3) ppm 20.9 [t, C(2,4)], 51.5 [d, 
C(l,5)], 63.8 [d, C(6,8)], 127.7 [d, C(2') or C(3')], 128.8 
[d, C(3') or C(2')], 133.4 [s, C(4')], 137.6 [s, C(l')], 212.9 
[s, C(9)]; 15N NMR (CDClJ) ppm 44.24 [N(7)]; 77Se 
NMR (CDCh) ppm 122.66 [Se(3)]. 
,Q-CIC6i4 
HN 1 
• ~g-CIC6H4 
~Se 
0~ 
0~ 
p-CIC;i;: 
g-CIC6H4 
Se 
(53) 
(54) 
EXAMPLE XV 
6,8-Diphenyl-3-selena-7-azabicyclo[3.3:l]nonane (55) 
6,8-Diphenyl-3-selena-7-azabicyclo[3.3. l]nonan-
9-one (0.89 g, 2.5 mmol) and hydrazine (95%, 3.0 g, 89 
mmol) were dissolved in triethylene glycol (40 mL). 
This solution was placed in a jacketed flask equipped 
for simple distillation under a rapid stream of nitrogen. 
Water was boiled in the jacket which heated the reac-
tion mixture to about 100° C. The solution was stirred at 
this temperature for 2 hours. Potassium hydroxide 
(85%, 1.0 g, 15 mmol) was added and the temperature 
was increased to about 208° C. by boiling tetralin in the 
jacket. As the temperature increased a gas evolved, 
presumably nitrogen. After stirring at this temperature 
for 4 h, 3 mL of water and excess hydrazine had dis-
tilled out. The reaction mixture was cooled to 60° - 70° 
C. and was then poured into ice-water (200 mL). The 
filtered solid was recrystallized (ether, decolorized car-
bon) to give 0.63 g (74%) of amine 6,8-diphenyl-3-
selena-7-azabicyclo[3.3.l]nonane as white needles: mp 
193.5°-195.0° C. (dee); IR (KBr) cm-13250 (N-H); IH 
NMR (C6D6) 80.83 [dt, 1 H, H(9), J = 12.0, 1.5 Hz], 1.34 
[m, 1 H, H(7)], 1.78 [m, 2 H, H(l,5)], 2.00 [dd, 2 H, 
H(2,4)ax, J = 12.0, 1.4 Hz], 2.33 [m, 1 H, H(9)], 2.84 [dd, 
2 H, H(2,4)eq, J = 12.0, 2.0 Hz], 4.34 [d, 2 H, H(6,8), 
J =2.0 Hz], 7.1-7.4 [m, 10 H, ArH]; 13C NMR (D6O6@ 
so· C.) ppm 25. 1 [C(2,4)], 27.2 [C(9)], 34.5 [C(l,5)], 62.0 
[C(6,8)], 126.9 [C(2') or C(3')], 127.2 [C(4')], 128.7 [C(3') 
or C(2')], 151.9 [C(l')]; 15N NMR (C6D6) ppm 55.68 
[N(7)]; 77Se NMR (C6D6 @ so· C.) ppm 2.38 [Se(3)]. 
Analysis calculated for C19H21NSe: C, 66.66; H, 6.18; 
N, 4.09; Se, 23.06. Found: C, 66.82; H, 6.34; N, 3.97; Se, 
22.82. 
Ph 
I 
HN tPh 
~Se 
(55) 
EXAMPLE XVI 
6,8-Di(2-thiophene)-3-selena-7-azabicycio[3.3. l ]nonane 
(56) 
6,8-Di(2-thiophene)-3-selena-7-azabicyclo[3.3. l ]-
nonan-9-one (1.00 g, 2.71 mmol) and anhydrous hydra-
zine (95%, 1.0 g, 30 mmol) were dissolved in triethylene 
23 
4,910,311 
24 
glycol (40 mL) which was contained in a jacketed flask 
equipped for distillation. By boiling water in the jacket, 
the reaction mixture was heated to 100° C. and stirred at 
this temperature for 2 hours. Potassium hydroxide 
(85%, 2.0 g, 30 mmol) was added in one portion and the 5 
water in the jacket then replaced by xylene which, 
when boiled, brought the temperature of the reaction 
mixture to 140°-145° C. Stirring was continued at this 
temperature for 5 hours. After cooling to room temper-
ature, the reaction mixture was poured into ice-cold 10 
water (200 mL) after which a precipitate immediately 
formed. This mixture was set aside at room temperature 
overnight and was then filtered. The filtrate was taken 
up in boiling benzene and treated with decoloring car-
bon. The benzene was evaporated (aspirator) and the 15 
residue was recrystallized in 95% ethanol to give 0.64 g 
(67%) of 6,8-di(2-thiophene)-3-selena-7-azabicy-
clo[3.3. l]nonane as a light tan solid: mp 183°-185° C. 
(dee); IR (KBr) cm-1 3270 (N-H); lH NMR (DCCl3) 
61.28 (d, I H, H(9), 1 = 13 Hz, 2 Hz], 1.78 [br s, 1 H, 20 
H(7)], 2.18 [br s, 2 H, H(l,5)], 2.32 [d, 2 H, H(2,4)ax, 
1 = 12 Hz], 2.50 [m, I H, H(9)], 3.20 [dd, 2 H, H(2,4)eq, 
1 = 13 Hz], 4.79 [d, 2 H, H(6,8), 1 =4 Hz], 6.96 [dd, 2 H, 
ArH], 7.01 [2 H, d, ArH], 7.21 [d, 2 H, ArH]; 13C NMR 
(DCCb) ppm 25.0 [C(2,4)], 25.8 (C(9)], 34.6 [C(l,5)], 25 
57.1 (C(6,8)], 122.2 [C(4')], 122.6 [C(2')], 126.1 [C(3')], 
150.7 (C(l')]; 15N NMR (DCCl3) ppm 60.10 [N(7)]; 77Se 
NMR (DCCl3) ppm 4.05 (Se(3)]. 6,8-Di(2-thiophene)-3-
selena-7-azabicyclo(3.3. l ]nonane proved difficult to 
purify for satisfactory analysis and was converted to 30 6,8-Diphenyl-3-selena-7-azabicyclo(3.3. 1]-nonane Hy-
droperchlorate of Example XIX. 
(56) 
2.04 [br s, 2 H, H(l,5)], 2.28 [br d, 2 H, H(2,4)ax, 1 = 12 
Hz], 2.48 [m, 1 H, H(9)], 3.17 [dd, 2 H, H(2,4)eq, 1 = 12 
Hz, 4 Hz], 4.43 [d, 2 H, H(6,8), 1=5 Hz], 7.26-7.50 (m, 
8 H, ArH]; l3C NMR (DCCl3) ppm 25.1 [C(2,4)], 26.9 
[C(9)], 33.8 [C(l,5)], 60.9 [C(6,8)], 127.9, 128.6, 132.6 
[C(4')], 145.7 [C(l')]; ISN NMR (DCCb) ppm 55.37 
[N(7)]; 77Se NMR (DCCb) ppm -0.79 [Se(3)]. 
6,8-Di( 4-chorophenyl)-3-selena-7-azabicyclo[3.3. l-
]nonane proved exceedingly difficult to obtain in pure 
form and give a satisfactory analysis. Thus, it was con-
verted to the hydroperchlorate salt 6,8-di(4-chloro-
phenyl)-3-selena-7-azabicyclo(3.3. l ]nonane hydroper-
chlorate of Example XXI which analyzed well. 
(57) 
EXAMPLE XVIII 
6,8-Di( 4-chorophenyl)-3-selena-7-azabicyclo[3.3.1 ]no-
nane (58) 
Endo,endo 6,8-di( 4-chlorophenyl)-3-selena-7-
azabicyclo(3.3.1 ]nonan-9-one (the endo,exo isomer) 
(2.00 g, 4.71 mmol), anhydrous hydrazine (95%, 2.0 g, 
60 mmol), and triethylene glycol (35 mL) were placed 
in a 60-mL, two-necked, jacketed, round-bottomed 
flask along with a magnetic stirring bar. This mixture 
s~ HNW 
35 was heated to 100° C. by boiling water in the jacket of 
the reaction flask. Stirring at this temperature under a 
stream of nitrogen was continued for 2 hours at which 
time potassium hydroxide (85%, 5.0 g, 76 mmol) was 
bl}e 40 added. The temperature of the resulting mixture was increased to 140° -145° C. by boiling xylene in the jacket 
of the reaction flask. After stirring at this temperature 
for 3 h, the resulting solution was cooled ( 60° - 70° C. 
EXAMPLE XVII 
I 45 
6,8-Di( 4-chorophenyl)-3-selena-7-azabicycl6(3.3. I ]no-
nane (57) 
Endo,exo 6,8-di( 4-chlorophenyl)-3-selena-7-azabicy-
clo(3.3. l ]nonan-9-one (the endo,exo isomer) (2.00 g, 
4.71 mmol), anhydrous hydrazine (95%, 2.0 g, 60 50 
mmol), and triethylene glycol (35 mL) were placed in a 
jacketed, round-bottomed flask along with a magnetic 
stirring bar. The contents of the flask were heated to 
100° C. under a stream of nitrogen by boiling water in 
the jacket of the reaction flask. Stirring at this tempera- 55 
ture was continued for 3 hours after which time potas-
sium hydroxide (85%, 5.0 g, 76 mmol) was added in one 
portion. The reaction mixture was then heated to 
140° -145° C. by boiling xylene in the jacket. After 4 
hours at this temperature, the resulting solution was 60 
cooled (60°-70° C.) and was poured into water (100 
mL) which precipitated a cream-colored solid. This 
solid was filtered and washed with water. Recrystalliza-
tion (twice, absolute ethanol, deodorizing carbon) gave 
6,8-di(4-chlorophenyl)-3-selena-7-azabicyclo(3.3. l]no- 65 
nane as a light tan solid (0.91 g, 47%): mp 179°-180° C. 
(dee); IR (KBr) cm - 1 3260 (N-H); 1 H NMR (DCCIJ) 
61.30 [d, 1 H, H(7), 1 = 12 Hz], 1.74 [br s, I H, H(7)], 
and was poured into water (100 mL). This precipitated 
a light yellow solid which was filtered and washed with 
water. This solid was recrystallized (absolute ethanol, 
decolorizing carbon) to give 6,8-di(4-chorophenyl)-3-
selena-7-azabicyclo(3.3. l]nonane as a white powder 
(1.14 g, 59%): mp 163°-165° C. (dee); IR (KBr) cm-1 
3290 (N-H); 1H NMR (CDCl3) 62.04 [br s, 2 H, 
H(l,5)], 2.18 [d, 1 H, H(9), 1= 14 Hz], 2.25 [d, 2 H, 
H(2,4)ax, 1 = 12 Hz], 2.36 [d, 1 H, H(9), 1 = 13 Hz], 2.59 
[br s, 1 H, H(7)], 3.04 (dd, 2 H, H(2,4)eq, 1 = 12 Hz, 4 
Hz], 4.50 [d, 2 H, H(6,8), 1=3 Hz], 7.32-7.52 [m, 8 H, 
ArH]; 13C NMR (CDCL3) pmm 17.7 [C(2,4)], 30.4 
[C(l,5)], 35.0 (C(9)], 64.0 [C(6,8)], 127.9, 128.5, 132.6 
[C(4')], 141.1 [C(l')]; 15N NMR (CDCL3) ppm 50.52 
[N(7)]; 77Se NMR (CDCl3) ppm 101.86 (Se(3)]. 
(58) 
4,910,311 
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EXAMPLE XIX 
6, 8-Diphenyl-3-selena-7-azabicyclo[3.3.1 ]nonane 
Hydroperchlorate (59) 
5 
A solution was made of 6,8-diphenyl-3-selena-7-
azabicyclo(3.3. l]nonane (0.63 g, 1.8 mmol) in benzene 
(100 mL). Perchloric acid (60%, 1.0 g, 6.0 mmol) was 
added dropwise, very slowly with swirling. The result-
ing mixture was allowed to stand at room temperature 10 
with occasional swirling for 3 hours. The orange solid 
(60) 
which formed was filtered and recrystallized (metha- EXAMPLE XXI 
nol) to give 0.62 g (78%) of 6,8-diphenyl-3-selena-7- 6,8-Di(4-chlorophenyl)-3-selena-7-azabicyclo[3.3.l]no-
azabicyclo[3.3.l]nonane hydroperchlorate as white nee- 15 nane Hydroperchlorate (61) 
dies: mp 288.0°-289.0° C. (dee, sealed tube); 1H NMR 6,8-Di(4-chorophenyl)-3-selena-7-azabicyclo[3.3. l-
(DMSO-d6) 61.78 [br d, 1 H, H(9), J = l3.0 Hz], 2·36 [br ]nonane (1.00 g, 2.43 mmol) was dissolved in ether (200 
d, 2 H, H(2,4)ax, J = 13.0 Hz], 2.59 [m, 3 H, H(l.5) and mL). Perchloric acid (60%, 1.0 g, 6.0 mmol) was added 
H(9)], 3.16 [dd, 2 H, H(2,4)eq, 1=12.0, 2.0 Hz], 4.73 [br 20 slowly with vigorous swirling. The resulting mixture 
d, 2 H, H(6,8), 1=3.0 Hz], 7.19-7.70 [m, 10 H, ArH], wasallowedtostandfor24hourswithoccasionalswirl-
8.72 [m, 1 H, H(7)ax], 9.67 [m, 1 H, H(7)eq]; 13C NMR ing. The yellow-orange solid which formed was filtered 
(DMSO-d6) ppm 23.5 [C(2,4)], 26.6 [C(9)], 31.2 [C(l,5)], and recrystallized (twice, absolute ethanol, decolorizing 
61.5 [C(6,8)], 128.5, 128.7, 128.6, 137.0 (C(l')]; 15N carbon) to give 6,8-di(4-chlorophenyl)-3-selena-7-
NMR (DMSO-d6) ppm 57.91 [N(7)]; 77Se NMR 25 azabicyclo[3.3.l]nona~e hydr?~erc~lorate a.5i a white 
(DMSO-d6) ppm 1.16 [Se(3)]. Analysis calculated for powder (0.46 g, 37%). mp 272 274 C. (dee), H NMR (DMSO-d6) 61.77 [d, l H, H(9), J = 12.0 Hz], 2.36 [d, 2 
C19H22CINO4Se: C, 51.54; H, 5.01; N, 3.16; Se, 17.83. H, H(2,4)ax, J=l0.8 Hz], 2.53 [m, 2 H, H(l,5)], 3.14 [d, 
Found: C, 51.52; H, 4.94; N, 3.34; Se, 17.65. 2 H, H(2,4)eq, J = 10.5 Hz], 3.38 [br s, 1 H, H(9)], 4.76 [br 
30 s, 2 H, H(6,8)], 7.50-7.75 [m, 8 H, ArH], 8.77 [br s, 1 H, 
(59) H(7)], 9.59 [br s, 1 H, H(7)]; 13C NMR (DMSO-d6) ppm 
23.5 [C(2,4)], 26.5 [C(9)], 31.1 [C(l,5)], 60.6 [C(6,8)], 
128.5, 130.9, 133.8 (C(4')], 136.1 [C(l')]; 15N NMR 
(DMSO-d6) ppm 57.67 [N(7)]; 77Se NMR (DMSO-d6) 
35 ppm 2.25 [Se(3)]. Analysis calculated for 
EXAMPLE XX 
6, 8-Di(2-thiophenyl)-3-selena-7-azabicyclo[3.3: l ]no-
40 
nane Hydroperchlorate (60) 
C19H20Cl3NO4Se: C, 44.60; H, 3.94; N, 2.47. Found: C, 
44.53; H, 3.84; N, 2.74. 
(61) 
EXAMPLE XXII 
6,8-Di(2-chloropheny 1)-3-selena-7-azaoicyclo[3 .3.1 ]no-
A solution was made of 6,8-di(2-thiophene)-3-selena-
7-azabicyclo[3.3. l]nonane (0.5 g, 1.4 mmol) in benzene 
(200 mL) and isopropyl alcohol (10 mL). To this solu-
tion was added 60% HCIO4 (0.5 g, 3.0 mmol) dropwise 45 
slowly causing a white precipitate to form. This precipi-
tate quickly became yellow. The solvent was decanted 
d h l.d 11· d · (" 1 1 nane Hydroperchlorate (62) an t e so 1 was recrysta 1ze twice 1sopropy a co-
ho!, decolorized carbon) to give 0.4 g (63%) of 6,8-di(2- 50 6,8-Di(4-chorophenyl)-3-selena-7-azabicyclo[3.3. l-
thiophenyl)-3-selena-7-azabicyclo[3.3. l]nonane hy- ]non~ne (1.00 g, 2.43 mmol) was dissolved in eth~r (2~ 
droperchlorate as white needles: mp 285• C. (dee); IH mL) ma 500 mL, round-bottomed flask. Per_chlon~ ~c1d 
NMR (DMSO-d ) 61.78 [d l H H(9) J = 14 Hz] 2_36 (60%, 1.0 ~• 6.0 ~mo!) was added slowly with sw1rlmg. 6 
' ' ' ' The resultmg mixture was allowed to stand at room 
[d, 2 H, H(2,4)ax, J = 14 Hz], 2.44 [m, l H, H(9)], 2.66 [br 55 temperature for 24 hours with occasional swirling. The 
s, 2 H, H(l,5)], 3.19 [dd, 2 H, H(2,4)eq, J = 12 Hz, 3 Hz], orange solid which formed was filtered and recrystal-
5.07 [m, 2 H, H(6,8), 7.16 [dd, 2 H, H(3'), J=4 Hz, 1=6 lized (absolute ethanol, decolorizing carbon) to give 
Hz], 7.43 [d, 2 H, H(2'), J=4 Hz], 7.69 [dd, 2 H, H(4'), 6,8-di(2-chlorophenyl)-3-selena-7-azabicyclo[3.3.l]no-
J =3 Hz, J =6 Hz], 9.36 [br s, l H, H(7)], 9.61 [br s, l H, nane hydroperchlorate (0.36 g, 29%) as white needles: 
H(7)]; 13C NMR (DMSO-d6) ppm 23.5 [C(2,4)], 26.2 60 mp 264°-265° C. (dee); 1H NMR (DMSO-d6) 62.16 [d, 
[C(9)], 32.5 [C(l,5))], 56.1 [C(6,8)], 127.3 [C(2') ofC(4')], 1 H, H(9), J = 12.1 Hz], 2.29 [d, 2 H, H(2.4)a.T, J = 12.7 
127.6 [C(4')] or C(2')], 129.2 [C(3')], 138.9 [C(l')]; 15N Hz], 2.50 [m,>3 H, H(l,5), H(9)], 3. 13 [d, 2 H, H(2,4)eq, 
NMR (DMSO-d ) 62 39 [N(7)]- 77S NMR J = 12.3 Hz], 5.07 [d, 2 H, H(6,8), J =8.5 Hz], 7.58-7.90 6 ppm · , e [m, 8 H, ArH], 9.18 [br s, 1 H, H(7)], 10.46 [br s, 1 H, 
(DMSO-d6) ppm 5.11 [Se(3)]. Analysis calculated for 65 H(7)]; 13C NMR (DMSO-d6) ppm 17. 7 [C(2,4)], 29. 7 
C1sH13CINO4S2Se: C, 39.61; H, 3.99; N, 3.08; ~. 14.10; [C(l,5)], 32.0 [C(9)], 63.7 [C(6,8)], 128.6, 128.9, 133.2 
Se, 17.36. Found: C, 39.81; H, 3.97; N, 3.10; S, 14.35; Se, [C(4')], 134.5 [C(l')]; 15N NMR (DMSO-d6) ppm 49.57 
17.18. [N(7)]; 77Se NMR (DMSO-d6) ppm 74.96 [Se(3)]. Anal-
.. 
27 
4,910,311 
28 
ysis calculated for C19H20Cl3NO4Se.C2HsOH: C, 45.22; 
H, 4.70; N, 2.51; Se, 14.16. Found: C, 44.93; H, 4.39; N, 
2.58; Se, 14.43. 
(62) 5 
mmol), and methanol (100 mL). The reaction time was 
24 hours and the aqueous workup was as described 
previously. Instead of the distillation described, the 
crude oil from the workup was then digested in Skelly 
B (300 mL) on a steam bath for 0.5 hours. The hot 
supernatant was decanted from the yellow residue and 
evaporated (aspirator followed by vacuum pump, room 
temperature 0.02 mm Hg, 20 min). This afforded N,N' -
dibenzyl-3, 7-diazabicyclo[3.3. l]nonan-9-one (6.84 g, 
EXAMPLE XXIII 
N,N' -Dibenzyl-3, 7-diazabicyclo[3.3. l]nonan-9-one (63) 
10 85.4%) as a white oil that did not solidify after 3 days at 
-10° C. The 1H and 13C NMR spectra of this oil were 
virtually identical to that described for the ketone pro-
duced in Example XXIII via method A and the material 
Following a procedure similar to that disclosed in 15 
U.S. Pat. No. 3,962,449, a three-necked, 50-mL, round-
bottomed flask was fitted with a dropping funnel (60 
mL), a condenser with an N2 inlet, a heating mantle, and 
a magnetic stirrer. This flask was charged with a solu-
tion of benzylamine (2.68 g, 25.0 mmol) and glacial 20 
acetic acid (1.54 g, 25.8 mmol) in methanol (25 mL). To 
this solution was added paraformaldehyde (1.58 g, 52.5 
mmol); then the apparatus was flushed with N2 and the 
mixture was brought to reflux with stirring. After 15 
min, a solution of l-benzyl-4-piperidone (4.73 g, 25.0 25 
mmol) and glacial acetic acid (1.50 g, 25.0 mmol) in 
methanol (18 mL) was added over 0.5 hours. The result-
ing orange solution was then boiled at reflux for an 
additional 9.5 hours. The mixture was then cooled to 
room temperature and the solvent was evaporated (as- 30 pirator) to give an orange oil. Water (SO mL) and KOH 
pellets (85%, 3.30 g, 50.0 mmol) were added, and the 
resulting oily, orange suspension was extracted 
(CH2Cl2, 3 X 50 mL). The organic extracts were com-
bined and dried (MgSO4, overnight). Filtration of the 35 
mixture followed by evaporation (aspirator) afforded an 
orange oil which was vacuum distilled (8 X 10-7 mm 
Hg, diffusion pump). At 106°-108° C. there was col-
lected a colorless oil (0.36 g), the 13C NMR of which 
was identical to 1-benzyl-4-piperidone. A second frac- 40 
tion (bp 180°-205° C.) was collected as a yellow oil but 
with substantial decomposition of the residue. This 
second fraction was redistilled ( 180° -185° C., 
LOX 10- 6 mm Hg) to yield again a yellow oil. This oil 
was dissolved in hot Skelly B (80 mL) and, upon cool- 45 ing to -10° C., pure N,N'-dibenzyl-3,7-diazabicy-
clo(3.3.l]nonan-9-one (2.53 g, 31.6%) was precipitated 
as a white solid: mp 61°-63° C. (literature 70°-71° C.). 
The compound was used in the next step without fur-
ther purification. The spectroscopic data for this com- 50 pound were: IR (KBr) cm- 1 2963, 2822, 1738, 1721, 
748, 703 lH NMR (DCCl3) 62.52 [br s, 2 H, H(l,5)], 
2.77, 2.78 [two d, J = 10.7 Hz, 4 H, H(2,4,6,8)ax], 3.00 
[br d, J = 10.S Hz, 4 H, H(2,4,6,8)eq], 3.53 [s, 4 H, 
ArCH2], 7.23-7.30 [m, 10 H, ArH]; 13C NMR (DCCl3) 55 ppm -46.7 [d, C(l,5)], 58.01 [f C(2,4,6,8)], 61.1 [t, 
ArCH2], 126.90 [d, p-ArC], 128.02 [d, o- or m-ArC], 
128--:S3 [d, m- or o-ArC] 138.02 [s, i-ArC], 214.0 [s, C(9)]; 
15N NMR (DCCl3) ppm 39.25 "[N(3,7)]. 
proved to be satisfactory for use in the following Exam-
ples XXV and XXVL 
EXAMPLEXXV 
N,N' -Dibenzyl-3, 7-diazabicyclo[3.3. l ]nonane 
Hydroperchlorate (64) 
(63) 
Following a procedure similar to that disclosed in 
U.S. Pat. No. 3,962,449 for the synthesis ofN,N'-diben-
zyl-3, 7-diazabicyclo[3.3. l]nonane, a jacketed, two-
necked, 70-mL flask was fitted with a lower take-off 
condenser with an N2 inlet and a receiving flask, a ther-
mometer, a condenser on the jacket, a magnetic stirrer, 
and a heating mantle. This flask was charged with N ,N' -
dibenzyl-3,7-diazabicyclo[3.3. l]nonan-9-one (2.00 g, 
6.24 mmol), hydrazine hydrate (85%, 1.10 g, 18.7 
mmol), KOH pellets (85%, 2.06 g, 31.2 mmol), and 
triethylene glycol (25 mL). The apparatus was flushed 
with N2, and the mixture heated at 120° C. for 0.5 hours 
using tetralin (bp 207° C.) in the jacket. The reaction 
mixture was then allowed to boil at reflux for 5 hours. 
The temperature slowly increased to 207° C. with re-
moval of the volatile distillates and with the evolution 
of N2: The reaction mixture was cooled to room tem-
perature and was poured, along with the distillate, into 
cool water (30 mL), which resulted in the formation of 
a white suspension. This was extracted (ether, 4 X 30 
mL), and the combined extracts were washed succes-
sively with NaOH solution (10%, 30 mL), H2O (30 
mL), and NaCl solution (saturated, 30 mL). After dry-
ing (Na2SO4, overnight), the solution was filtered and 
evaporated (aspirator) to give the crude amine, N,N' -
dibenzyl-3,7-diazabicyclo[3.3. l]nonane as a yellow oil 
(1.34 g, 70.1 %). This oil was dissolved in C6H6 (20 mL) 
and treated dropwise over 15 min with a solution of 
HClO4 (60%, 2.20 g, 13.1 mmol) in 2-propanol (5 mL) 
to give a dark solution. This solution was stirred (mag-
EXAMPLE XXIV 
N,N' -Dibenzyl-3,7-diazabicyclo[3.3. l]nonan-9-one (63) 
In a minor modification of the previous procedure, a 
solution of l-benzyl-4-piperidone (4.73 g, 25.0 mmol) 
and glacial acetic acid (I.SO g, 25.0 mmol) in methanol 
(25 mL) was added as before to a boiling mixture of 
paraformaldehyde (6.00 g, 200 mmol), glacial acetic 
acid (1.62 g, 27.0 mmol), benzylamine (2.68 g, 25.0 
60 netic) for I hour after which it was concentrated (5 
mL). Addition of ether (20 mL) precipitated the salt as 
a dark brown solid. Filtration and recrystallization 
(aqueous ethanol, 20 mL, decolorizing carbon) afforded 
a first crop of N,N' -dibenzyl-3, 7-diazabicyclo[3.3. I ]no-
65 nane hydroperchlorate (0.652 g) as the monoperchlo-
rate; mp 221 ° -222° C. Concentration of the mother 
liquor to 7 mL gave a second crop (0.126 g, total: 0.778 
g, 43. 7% total), mp 220° -222° C. The spectroscopic 
.. 
29 
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data for this compound were: IR (KBr) cm-1 2960, 
2841 (C-H), 2800-2600 (N+-H), 1100, 1080 (Cl-O); 
1H NMR (DMSO-d6) 61.72 [br s, 2 H, H(9)], 2.14 [br s, 
2 H, H(l,5)], 2.77 [d, J = 13 Hz, 4 H, H(2,4,6,8)]ax], 3.13 
[d, J = 13 Hz, 4 H, H(2,4,6,8)eq], 3.43 [br s, 1 H, 5 
N+-H], 3.86 [s, 4 H, ArCH 2], 7.30-7.48 [m, 10 H, 
ArH];"Tic NMR (DMSO-d6)ppm 27.4 [d, C(l,5)], 29.54 
[t, C(9)], 56.97 [t, C(2,4,6,8)], 60.4 [t, ArCH2], 128.2 [d, 
p-ArC], 128.4 [d, o- or m-ArC], 129.6 [d;-m- or o-ArC], 
133.30 [s, i-ArC]; 15NMR-(DMSO-d6) ppm 54]9 10 
[N(3,7)]. AnalysTs calculated for C21H21ClN2O4: C, 
61.99; H, 6.69; Cl, 8.71; N, 6.88. Found: C, 61.92; H, 
6.84; Cl, 8.71, N, 6.82. [Although the N,N'-dibenzyl-3,7-
diazabicyclo[3.3.l]nonane hydroperchlorate was sup-
posedly synthesized (see Ruenitz, P. C. and Smissman, 15 
E. E. J. Heterocy. Chem. 1976, 13, 1111), the material 
was not a true pure compound since it had a melting 
range of 210• -217° C. and orange crystals were re-
ported; therefore, the above data is for the true, pure 
compound] 20 
(64) 
d6) ppm 52.89 [N(3,7)]. Analysis calculated for 
C23H31ClN2O6: C, 59.16; H, 6.69; Cl, 7.59; N, 6.00. 
Found: C, 58.98; H, 6.81; Cl, 7.86; N, 6.28. 
Ph 
( CI04-
(65) 
N 
"\.+ 
H 
N\ 
H3CO Ph 
OCH3 
EXAMPLE XXVII 
7-Benzyl-9,9-dimethoxy-3-thia-7-azabicyclo[3.3. l]no-
nane Hydroperchlorate (66) 
A one-necked, 100-mL round-bottomed flask was 
fitted with a Soxhlet containing 3A molecular sieves (30 
g), a condenser, an N2 inlet, a heating mantle, a mag-
netic stirrer, and a heating mantle. The effective cycling 
volume of the Soxhlet was approximately 15 mL. The 
25 flask was charged with a solution ofN-benzyl-3-thia-7-
azabicyclo[3.3.l]nonan-9-one [1.00 g, 4.04 mmol] in 
methanol (20 mL) and benzene (20 mL). To this solu-
tion was added HCIO4 (60%, 2.03 g, 12.1 mmol) in one 
EXAMPLE XXVI 
N ,N' -Dibenzyl-9,9-dimethoxy-3, 7-diazabicyclo[3.3.1-
]nonane Hydroperchlorate (65) 
30 
portion. The volume of the methanol used was such that 
the perchloric acid always remained in solution and did 
not become completely dry. The apparatus was flushed 
with N2 and the pale yellow solution was heated at 
A one-necked, 100-mL, round-bottomed flask was 
reflux with stirring and cycling through the Soxhlet for 
equipped with a Soxhlet containing 3A molecular sieve 
(30 g), a condenser with Nz inlet, a magnetic stirrer and 35 24 hours. The solution was cooled to room temperature 
a heating mantle. The effective cycling volume of the and concentrated to about 5 mL. Ether (20 mL) was 
Soxhlet was approximately 20 mL. The flask was added, thus precipitating the salt as a powder. This was 
charged with a solution of N,N' -dibenzyl-3,7-diazabicy- filtered, washed with ether (5 mL), and dissolved in hot 
clo[3.3.l]nonan-9-one (1.00 g, 3.12 mmol) in CH3OH methanol (20 mL, decolorizing carbon). Trituration 
(25 mL) and C6H6 (25 mL) to which was added HClO4 40 with ether (25 mL), followed by standing for 24 h, 
(60%, 1.50 g, 8.96 mmol) in one portion. The volume of afforded 7-benzyl-9,9-dimethoxy-3-thia-7-azabicy-the methanol used was such that the perchloric acid 
always remained in solution and did not become com- clo[3.3.l]nonane hydroperchlorate (0.7345 g, 46.2%) as 
pletely dry. The apparatus was flushed with Ni and the small white crystals: mp 193° -194° C. (dee); IR (KBr) 
colorless solution was heated to reflux with cycling 45 cm- 1 2800-2600 (N+-H), 1090 (Cl-O); IH NMR 
through the Soxhlet. After 24 h, the now pale yellow (DMSO-d6) 62.58 [br s, 2 H, H(l,5)], 2.75 [d, J = 14 Hz, 
solution was cooled to room temperature and concen- 2 H, H(2,4)ax], 3.15-3.18 [m, 8 H, H(2,4)eq,C!!3O], 3.38 
trated to about 5 mL. Upon standing for a few minutes, [dd or br t, J = 12 Hz, 2 H, H(6,8)ax], 3.60 [d, J = 12 Hz, 
a product precipitated as a white solid which was fil. 
tered, washed with C6H6 (10 mL), and recrystallized 50 H(6,8)eq], 4·33 [d, 1=5 Hz, 2 H, ArCH2], 7.49- 7-62 [m, 
(CH3OH, 80 mL) to afford the monoperchlorate N,N'- 5 H, Ar!!], 9.28 [br s, 1 H, N+-!!]; 13C NMR (DMSO-
dibenzyl-9,9-dimethoxy-3,7-diazabicyclo(3.3.l]nonane d6) ppm 28.78 [t, C(2,4)], 32.20 [d, C(l,5)], 46.60 [q, 
hydroperchlorate (0.9103 g) as small white crystals, mp fH3O], 47.00 [q, fH3O], 54.42 [t, C(6,8)], 60.24 [t, 
223.6°-224.0° C. (dee). The mother liquor was concen- ArCH2], 95.1 [s, C(9)], 129.0 [d, o- or m-ArC], 129.46 [s, 
trated to approximately 10 mL. Upon cooling at -10° 55 i-A7f], 130.l [d, p-Arf], 130.2 [d, m- or o-Arf]; 15N 
C. over,night, a second crop ofN,N'-dibenzyl-9,9-dime- NMR (DMSO-d6) ppm 53.49 [N(7)]. Analysis calcu-
thoxy-3, 7-diazabicyclo[3.3. l ]nonane hydroperchlorate 
b · d (89 4 t l o 9997 68 6m l) lated for C26H24ClNO6:-C, 48.79; H, 6.14; Cl, 9.00; N, was o tame . mg, to a : . g, . 70 tota , mp 
219°-220° C. (dee). The spectral data were as follows: 3-56; S, 8.l4. Found: C, 48.73; H, 6.09; Cl, 9.39; N, 3.54; 
IR(KBr)cm-12800-2600(N+-H), llOO(Cl-O); IH 60 S, 8.40. 
NMR (DMSO-d6) 62.35 [br s, 2 H, H(l,5)], 2.90 [d, 
J = 13 Hz, 4 H, H(2,4,6,8)ax], 3.08 [d, J = 13, 4 H, 
H(2,4,6,8)eq], 3.14 [s, 6 H, CH3O], 3.88 [s, 4 H, ArCH2], 
7.38-7.54 [m, 10 H, ArH], 9.84 [br s, 1 H, N+--H]; 
13C-NMR (DMSO-d6) ppm 33.0 [d, C(l,5)], 46.96 [q, 65 
CH3O], 53.8 [t, C(2,4,6,8)], 59.56 [t, ArCH2], 95.36 [s, 
C(9)], 128.22 [d, p-ArC], 128.4 [d, O· or m-ArC], 129.62 
[d, m- or o-Arf], 133A-5 [s, i-Arf]; 15N NMRDMSO-
(66) 
31 
EXAMPLE XXVIII 
4,910,311 
32 
endo,exo- and 
endo,endo-7-Benzyl-2,4-bis(2-chlorophenyl)-3, 7-
diazabicyclo[3.3.1 ]nonan-9-ones (67),(68) 5 
A three-necked, 50 mL, round-bottomed flask was 
fitted with a condenser, an addition funnel, a thermome-
ter, magnetic stirrer, a heating mantle, and an N2 inlet. 
This flask was charged with ammonium acetate 
(NH4OAc, 2.31 g, 30.0 mmol) and ethanol (10 mL) and 10 
the flask flushed with Nz. The slurry was warmed to 40° 
C. with stirring until all NH4OAc dissolved, then the 
solution was cooled to room temperature. A solution of 
2-chlorobenzaldehyde (5.67 g, 40.3 mmol), 1-benzyl-4-
piperidone (3.78 g, 20.0 mmol), and deoxygenated etha- 15 
nol (15 mL) was added in one portion. The resulting 
solution was slowly warmed to 70° C. over 30 minutes. 
Upon cooling to room temperature, a white precipitate 
(solid A) formed which was filtered and washed with 
dry ·ether (20 mL). These washings were combined with 20 
the original filtrate and this solution was cooled at - 10° 
C. for 1 hour to give a second solid precipitate (solid B) 
which was also filtered and set aside. Evaporation of the 
filtrate afforded an oily orange solid which was dis-
solved in ether (10 mL). Upon standing for 1 hour at 25 
- 10° C., a third white solid (solid C) precipitated. This 
too was filtered and set aside. Upon standing for 24 h, a 
fourth white solid (solid D) was precipitated, which 
was also filtered and set aside. Upon standing for 22 
days at - 10° C., a small amount of a fifth solid (solid E) 30 
precipitated which was treated as before. 
Solid A was recrystallized (2-propanol/HCCl3, 3: I, 
40 mL) to afford pure endo,exo-3-7-benzyl-2,4-bis(2-
chlorophenyl)-3, 7-diazabicyclo(3.3. l]nonan-9-one ( 1.06 
g) as long white needles: mp 184 ° -185° C.; IR(KBr) 35 
cm - I 3340 (N-H), 1733 (C==O); 1 H NMR (DCCl3) d 
1.61 [s, 1 H, N-H], 2.54, 2.56 (overlapping d, J = 12 Hz, 
and br s, 4 H, H(l,5) and H(6,8)ax], 3.49 [d, J = 12 Hz, 2 
H, H(6,8)eq], 3.73 [s, 2 H, ArCH2], 5.50 [br s, 2 H, 
H(2,4)], 7.14-7.80 [m, 13 H, ArHf 13C NMR (DCCl3) 40 
ppm 55.15 [d, C(l,5)], 58.77 [t, C(6,8)], 59.02 [d, C(2,4)], 
60.99 (t, ArCH2], 127.35, 127.48, 128.38, 128.44, 128.59, 
129.16, 12911, 132.15, 138.35, 142,63 [ArC], 211.95 [s, 
C(9)]; 15N NMR (DCCl3) ppm 38.31 [N(7)], 58.24 
[N(3)]. 45 
Solids B, C and E were combined and recrystallized 
(2-propanol/HCCl3, 3:1, 15 mL) to afford additional 
endo,exo-3-7-benzyl-2,4-bis(2-chlorophenyl)-3, 7-
diazabicyclo[3.3. l ]nonan-9-one (0.50 g, total: 1.56 g, 
17.3%) mp 184°-185° C. Solid D was also recrystallized SO 
from the same solvent system (15 mL) to afford endo, 
endo-7-benzyl-2,4-bis(2-chlorophenyl)-3, 7-diazabicy-
clo(3.3. l]nonan-9-one (0.36 g, 4.0%) as short white 
needles: mp 209.5°-210.0° C.; IR (KBr) cm- 1 3270 
(N-H), 1717 (C=O); 1H NMR (DCCl3) 02.54 [d, 55 
1=12 Hz, 2 H, H(6,8)ax], 2.76 [br s, 2 H, H(l,5)], 3.12 
[d, J = 12 Hz, 2 H, H(6,8)eq], 3.32 [s, 2 H, ArCH2], 4.70 
[br s, I H, N-H], 4.80 [br s, 2 H, H(2,4)], "f°15-7.60 
[m,ArH]; 13C NMR (DCCl3) ppm 50.90 [d, C(l,S)], 
55.50 [t, C(6,8)], 62.11 [d, C(2,4)], 62.54 [t, ArCH2], 60 
126.62, 127.44, 128.45, 128.57, 129.75, 129.81, 129.90, 
132.32, 136.66, 137.22 [ArC], 212.22 [s, C(9)]; 15N NMR 
(DCC'3) ppm 46.90 [N(7)f 54.45 [N(3)]. Analysis calcu-
lated for the endo, exo- isomer C20H24Cl2N2O: C, 69.18; 
H, 5.36; Cl, 15.71; N, 6.21. Found: C, 69.31, H, 5.20; Cl, 65 
15.83; N, 6.18. Analysis calculated for the endo, endo-7-
benzyl-2,4-bis(2-chlorophenyl)-3, 7-diazabicyclo[ 3. 3. 1-
]nonan-9-one of 17 Calcd. for C20H2-1ChN2O: C, 69. I 8; 
H, 5.36; Cl, 15.71; N, 6.21. Found: C, 69.33; H, 5.53; Cl, 
15.97; N, 6.09. 
0 
,9-CIC6H4 
1 NH 
IC6H4 
N\ 
Ph 
EXAMPLE XXIX 
. I 
endo,exo-7-Benzyl-2,4-bis(2-chlorophenyl)-3, 7-
diazabicyclo[3.3. l]nonan-9-one (67) 
(67) 
(68) 
A one-necked, 50-mL, round-bottom flask was fitted 
with a condenser, a magnetic stirrer, and an N2 inlet at 
the top of the condenser. The flask was charged with 
95% ethanol (SO mL) and the apparatus was flushed 
with Nz. This solvent was heated at reflux for 0.5 hours. 
Upon cooling to room temperature, 1-benzyl-4-piperi-
done (4.73 g, 25.0 mmol), 2-chlorobenzaldehyde (7.03 g, 
50.0 mmol), and ammonium acetate (5.78 g, 75.0 mmol) 
were added to the flask. The apparatus was again 
flushed with No and the mixture was allowed to stir at 
room temperat~re. The NH4OAc slowly dissolved over 
l hour and the formation of a small amount of white 
precipitate was noted shortly thereafter. Continued 
stirring at room temperature for S days gave additional 
white precipitate while the supernatant slowly devel-
oped a bright red-orange color. The precipitate (solid 
A) was filtered and washed with ether (SO mL). The 
washings were combined with the original filtrate. This 
solution was cooled at - 10° C. for 2 days, thus precipi-
tating additional white solid (solid B) which was filtered 
and washed with ether. The filtrate was evaporated 
(aspirator) to give an orange gum. Ether (100 mL) was 
added and the mixture was heated on a steam bath until 
a third, almost white solici separated from the orange 
supernatant. This was filtered, washed with ether and 
recrystallized (2-propanol/HCCl3, 3: !, 10 mL) to afford 
endo,endo-7-benzyl-2,4-bis(2-chloropheny 1)-3, 7-
diazabicyclo[3.3. l ]nonane (0.1983 g, 1.8%) as tiny nee-
dles, mp 207° -209° C. 
Solid A was recrystallized (2-propanol/HCCl3, 3: I, 
110 mL) to afford (3.14 g) as long white needles, mp 
184.0° -184.5° C. Solid B was recrystallized in the same 
solvent system (IS mL) to give endo,exo-7-benzyl-2,4-
bis(2-chlorophenyl)-3, 7-diazabicyclo(3.3. I ]nonan-9-one 
(0.40 g, total: 3.54 g, 31.3%), mp 184°-185° C. The IR, 
1 H and !3C NMR spectra for these products were iden-
tical to those given previously. 
EXAMPLE XXX 
endo,exo-7-Benzyl-2,4-bis(2-chlorophenyl)-3, 7-
diazabicyclo[3.3. l]nonane (69) 
A two-necked, jacketed flask with an N2 inlet was 
fitted with a thermometer, a lower take-off condenser, a 
magnetic stirrer, a heating mantle, and a condenser on 
the jacket. The flask was charged with endo,exo-7-ben-
zy l-2,4-bis(2-chlorophenyl)-3, 7-diazabicyclo[3.3. I ]no-
33 
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nan-9-one (0.80 g, 1.8 mmol) and triethylene glycol (50 (50 mL). Trituration with ether afforded, upon cooling, 
mL ), and the jacket charged with tetralin (bp 2070). The white cubic crystals which were filtered, washed with 
apparatus was flushed with N2 and warmed to 110° C. 
with stirring to dissolve the ketone. To this solution was ether, and dried to give endo,endo-7-benzyl-2,4-bis(2-
added in one portion hydrazine hydrate (85%, 0.52 g, 5 chlorophenyl)-3,7-diazabicyclo[3.3.l]nonane (1.11 g, 
10.4 mmol), and the resulting solution was stirred at 61%): mp 149°-151° C.; IR (KBr) cm-I 3250 (N-H); 
110° C. for 1 hour. Potassium hydroxide pellets (85%, IH NMR (DCCb) 62.04 [br s, 2 H, H(l,5)], 2.06 [d, 
5.00 g) were then added. The mixture was heated to 
195° C. over 4.5 hours until N2 evolution ceased, with J = 10 Hz, 1 H, H(9)], 2.17 [d, J = 10 Hz, 2 H, H(6,8)ax], 
the continuous distillation of volatiles. Upon cooling to 10 2.29 [d, J = 10 Hz, 1 H, H(9)], 2.82 [d, J = 10 Hz, 2 H, 
room temperature, the tan solution was poured into H(6,8)eq], 3.10 [s, 2 H, ArC!!2], 4.44 [br s, 1 H, N-!!], 
H2O (50 mL), and the resulting suspension was ex- 6 [b ( )] · g [ 3 H H] 13C d · h h 1 h (5 30 L) Th b. d 4. 8 rs, 2 H, H 2,4 , 7.0 -7.44 m, 1 , Ar_; tracte wit et y et er X m . e com me 
ether extracts were washed with NaOH solution (10%, NMR (DCCb) ppm 31.50 [d, C(l,5)], 35.87 [t, C(9)], 
50 mL) and dried (Na2SO4, overnight). Filtration fol- 15 54.86 [t, C(6,8)], 61.63 [d, C(2,4)], 64.31 [t, ArfH2], 
lowed by evaporation (aspirator) of the filtrate afforded 126.46, 127.33, 127.54, 128.25, 129.34, 129.80, 132.34, 
a yellow oil which was dissolved in hot ethanol (25 138.04, 140.20 [Arf]; 15N NMR (DCCb) ppm 47.43 
mL). Upon cooling, the product precipitated as white . 
plates which were filtered and dried to afford exo,exo- [N(7)], 53.80 [N(3)]. Analysis calculated for 
7-benzyl-2,9-bis(2-chlorophenyl)-3,7-azabicyclo[3.3. l- 20 C26H26Cl2N2: C, 71.39; H, 6.00; Cl, 16.21; N, 6.40. ]nonane (0.54 g, 69%): mp 136.4°-137.0° C.; IR (KBr) Found: C, 71.48; H, 6.04; Cl, 16.00; H, 6.65. 
cm-I 3300 (N-H); 1H NMR (DCCl3) 61.07 [dt, 
J = 12.3, 2.7 Hz, 1 H, H(9)endo], 1.18 [br s, 1 H, N-H], 
1.83 [br s, 2 H, H(l,5)], 2.09 [d, J = 10 Hz, 2 H, 
H(6,8)ax], 2.35 [d, J = 12.3 Hz, 1 H, H(9)exo], 3.08 [d, 25 J = 10 Hz, 2 H, H(6,8)ax], 3.50 [s, 2 H, ArCH2], 4.77 [d, 
1=2.5 Hz, 2 H, H(2,4)], 7.09-7.92 [m, 13 H~ArH]; 13C 
NMR (DCCb) ppm 24.55 [b, C(9)], 36.13 [d, C(l,5)], 
• 56.08 [d, C(2,4)], 58.76 [t, C(6,8)], 62.85 [t, ArCH2], 
126.79, 126.97, 127.52, 128.02, 128.08, 129.14, 129.27, 
132.38, 139.19, 145.66 [Are]; 15N NMR (DCCl3) ppm 3o 
38. 15 [N(7)], 50.48 [N(3)]. Analysis calculated for 
C26H26N2Ch: C, 71.39; H, 6.00; N, 6.40; CL, 16.21. 
Found: C, 71.17; H, 6.25; N, 6.32; Cl, 16.15. 
(70) 
EXAMPLE XXXII 
endo,exo-7-Benzyl-2,4-bis(2-chlorophenyl)-3, 7-
diazabicyclo[3. 3. l ]nonane Hydroperchlorate (71) 
p-CICoH4 
I. 
<69) 35 In a one-necked, 100-mL, round-j>ottomed flask, a 
HN 7 
IC6H4 
solution of endo,exo-7-benzyl-2,4-bis(2-chlorophenyl)-
3, 7-diazabicyclo[3.3. l]nonane (0.80 g, 1.83 mmol) in 
C6H6 (30 mL) was treated dropwise slowly with a solu-
N\ 
Ph 
EXAMPLE XXXI 
40 tion of HCLO4 (60%, 1.50 g, 8.96 mmol) in 2-propanol 
(5 mL) which resulted in the formation of a white pow-
dery precipitate. The flask was fitted with a condenser, 
and the mixture was heated on a steam bath for 15 min. 
endo,endo-7-Benzyl-2,4-bis(2-chlorophenyl)-3, 7-
diazabicyclo[3.3. l]nonane (7Ci) 
45 After cooling to room temperature, the precipitate was 
filtered and reccystallized in a minimum amount of 70% 
acetone to afford the monohydroperchlorate endo,exo-
7-benzyl-2,4-bis(2-chlorophenyl)-3, 7-diazabicy-
A jacketed two-necked flask with an N2 inlet was 
fitted with a thermometer, a lower take-off condenser 
with receiving flask, a magnetic stirrer_, a heating man-
tle, and a condenser on the jacket. This flask was 50 
charged with endo,endo-7-benzyl-2,4-bis(2-chloro-
phenyl)-3, 7-diazabicyclo[3.3. l ]nonane (1.87 g, 4.15 
mmol) and triethylene glycol (75 mL) and the jacket 
charged with tetralin. The apparatus was flushed with 
N2, and the mixture was heated to 110° C. with stirring 55 
to dissolve the ketone. Hydrazine hydrate (85%, 1.22 g, 
20.7 mmol) was added in one portion and the resulting 
solution was heated at 110° -120° C. for 1 hour. Potas-
sium hydroxide pellets (85%, 8.8 g) were then added 
and the resulting mixture was heated to 195° C. over 4 60 
hours with the distillation of volatiles and the evolution 
of N2. After cooling to room temperature, the solution 
was poured into H2O (50 mL) and the resulting suspen-
sion was extracted with ether (7X50 mL). The com-
bined ether extracts were washed with NaOH solution 65 
(10%, 100 mL) and dried (K2CO3, overnight). Filtra-
tion, followed by evaporation (aspirator), of the filtrate 
gave a yellow oil which was dissolved in warm ethanol 
clo[3.3. l]nonane hydroperchlorate as fine white crys-
tals: mp 246° -247° C. (dee); IR (KBr) cm- 1 3330 
(N-H), 2900-2600 (N+-H), 1110 (Cl-O); IH NMR 
(DMSO-d6) 61.70 [d, J = 14 Hz, 1 H, H(9)endo], 2.33 [d, 
J = 11 Hz, 2 H, H(6,8)ax], 2.38 [br s, 2 H, H(l,5)], 2.51 
[overlapping d, J = 14 Hz, H(9)exo and br s, DMSO], 
2.85 [d, J = 11 Hz, 2 H, H(6,8)eq], 3.70 [s, 2 H, ArC!!2], 
5.00 [d, J =8 Hz, H(2,4)], 7.32-7.94 [m, 13 H, Ar!!], 8.10 
[br s, 1 H, N-!!], 9.84 [br s, 1 H, N+-!!]; 13C NMR 
(DMSO-d6) ppm 24.54 [t, C(9)], 33.70 [d, C(l,5)], 55.94 
[t, C(6,8)], 56.85 [d, C(2,4)], 60.93 [t, C(lO)], 
127.55-130.88 [m, Arf], 132.63, 135.51, 137.09 [Arf]; 
15NMR (DMSO-d6) ppm 38.30 [N(7)], 54.60 [N(3)]. 
Analysis calculated for C26H21Cl3N2: C, 58.06; H, 5.06; 
Cl, 19.78; N, 5.21. Found: C, 58.16; H, 5.20; Cl, 19.65; N, 
5.16. 
35 
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and a heating• mantle. This flask was charged with para-
formaldehyde (1.20 g, 40.0 mmol), benzylamine (1.07 g, 
10.0 mmol), glacial acetic acid (0.66 g, 11.0 mmol), and 
methanol (20 mL). The apparatus was flushed with N2 
5 and the mixture boiled at reflux with stirring for 15 
minutes. To the mixture was added in one portion a 
solution of 4-thianone (0.58 g, 5.0 mmol) in methanol 
(10 mL) and the resulting mixture was heated at reflux 
for 9 hours during which the paraformaldehyde slowly 
10 dissolved and the solution turned yellow. The solution 
was then cooled to room temperature and allowed to 
EXAMPLE XXXIII stir an additional 10 hours. Evaporation afforded a yel-
endo,endo-7-Benzyl-2,4-bis(2-chlorophenyl)-3,7- low oil which was partitioned between ethyl ether (50 
diazabicyclo[3.3. l]nonane Hydroperchlorate (72) mL) and water (50 mL). The layers were separated and 
In a one-necked, 100-mL, round-bottomed flask, a 15 the pale yellow ether layer was allowed to stand for 24 
solution of endo,endo-7-benzyl-2,4_bis(2.chlorophenyl)- hours at - 10° C. A white crystalline solid precipitated 
3,7-diazabicyclo[3.3. l]nonane (0.4957 g, 1.14 mmol) in from this ethereal solution. This was filtered and set 
c6H6 (20 mL) was treated dropwise over 15 minutes aside. The filtrate was concentrated (aspirator) to half 
with HC1O4 (60%, 0.5 mL) with vigorous stirring. This 20 of the previous volume and allowed to stand for 3 
resulted in the precipitation of a white solid. The flask hours. A second crop of the white solid was precipi-
was fitted with a condenser and heated on a steam bath tated which was filtered, combined with the first crop, 
for an additional 5 minutes, followed by cooling to and recrystallized (95% ethanol, 30 mL) to afford 3,6-
room temperature. The solution was filtered and the dibenzylhexahydro-8a-methoxy-5H-4a,8-(methanothi-
cloudy filtrate set aside. Recrystallization of this solid 25 omethano)-2H-pyrido[3,4-e]-l,3-oxazine (0.93 g, 45%) (CH3OH, 30 mL) afforded the monoperchlorate en- as white needles: mp 147.2°-148.8° C.; IR (KBr) cm-1 
do,endo-7-benzyl-2,4-bis(2-chlorophenyl)-3, 7- 3030, 2940, 2830, 1365, 1358, 1104, 1067, 740, 704; lH 
diazabicyclo[3.3. l]nonane hydroperchlorate (0.1050 g) NMR (DCCl3) 32.08 [d, J = 12 Hz, 1 H, H(5)ax], 2.13 
as white crystals, mp 264.0° -264.5° C. (dee). The cloudy [br s, 1 H, H(8)], 2.37 [d, J = 12 Hz, 1 H, H(5)eq], 2.54 
benzene filtrate was evaporated to about 2 mL, and the 30 [dd, J = 12, 2 Hz, lH, H(9)ax], 2.62 [d, J = 11 Hz, 1 H, 
resulting oil was dissolved in hot CH3OH (30 mL). ArCH2], 2.74 [d, J = 10 Hz, 1 H, H(4)ax], 2.95 [d, J = 10 
Upon cooling to RT, additional salt precipitated as a Hz, lH, H(4)eq], 3.22 [s, 3 H, CH3O], 3.25 [d, J = 1 H, 
white powder which was filtered and recrystallized H(l l)eq], 3.31 [d, J = 13 Hz, 1 H, H(7)ax], 3.39 [dd, 
(CH3OH, 65 mL) to afford additional endo,endo-7-ben- J = 12, 2 Hz, I H, H(9)eq], 3.49 [d, J = 11 Hz, 1 H, 
zyl-2,4-bis(2-chlorophenyl)-3,7-diazabicyclo[3.3. l]no- ArCH2], 3.50 [d, J = 13 Hz, 1 H, H(7)eq], 3.55 [d, J = 13 
nane hydroperchlorate (0.3575 g, 74% total) as white 35 - ] [ ] [ Hz, 2 H, ArCH2 , 4.02 d, J = 8 Hz, 1 H, H(2)ax , 4.18 d, 
crystals, mp 260°-262° C. (dee). The spectroscopic data J=8 Hz 1 H,H(2)eq], 7.22-7.38 [m, 8 H, ArH], 7.58 [d, 
were as follows: IR (KBr) cm - 1 3300 (N-H), J = 8 Hz, 2 H, ArH]; l3C NMR (DCClJ) ppm 30.09 [t, 
2850-2700 (N+-H), 1090 (Cl-O); 1H NMR (DMSO- C(9)], 33.42 [d, C(S)], 34.56 [t, C(l 1)], 37.40 [s, C(4a)], 
d6) 32. 19 [d, J = 12 Hz, 1 H, H(9)], 2.35 [d, = 12 Hz, 1 H, 40 46.27 [q, CHJO], 55.38 [t, C(4)], 55.79 [t, C(5)], 57.32 [t, H(9)], 2.38 [br s, 2 H, H(l,5)], 3.02 [br s, 4 H, H(6,8)ax C(7)], 59.94 [t, ArCHi], 62.59 [t, ArCHz], 78.72 [t, C(2)], 
and eq], 4.08 [br s, 2 H, ArC!:!2], 4.88 [br s, 2 H, H(2,4), 96.93 [s, C(8a)], 12.6.48 [d, p-ArC]-;-127.10 [d, p-ArC], 
5.63 [br s, 1 H, N-!:!], 7.36-7.72 [m, 13, Ar!:!], l0. l4 [br 128.15, 128.30, 128.33, 128.53 [o- and m-ArC], 137.49[s, 
s, 1 H, N+-H]; 13C NMR (DMSO-d6) ppm 29.77 [d, · ] 66 [ · ]· 1s -C(l,5)], 31.3g [t, q 9)],. 52_97 [t, q 6,S)], 60_30 [t, 1-Arf, 139. s, 1-Arf, N NMR (DCCl3) ppm 46.42 
ArCH2], 60.84 [d, C(2,4)], 127.33, 127.40, 128.92, 129.26, 45 [N(3)], 35·92 [N(3)]. . . . 
129-:-89, 130.83, 131.1 8, 13 1.33, 136_33, 142_05, [Are]; _}.n a separate expenment under shg~tly different con-
lSN NMR (DMSO-d6) ppm 50_05 [N(7)], 52;56 [N(3)]. d1t1ons a second product was also isolated. A t~ree 
A I · I I t d c C H Cl N O C 58 05 H necked, 50 mL, round-bottomed flask was fitted with a na ys1s ca cu a e ,or 26 21 , , 4: , . ; , d • dd. · f 1 d · h N · I 5.07; Cl, 19.73; N, 5.21. Found: C, 5"s_07; H, 5_08; Cl, ropp~ng a 1t1on unne, a _con. enser wit an 2 met, 19 66- N 5 27 50 a heatmg mantle, a magnetic stirrer, and a stopper on 
· ' ' · · the third neck. The flask was charged with a slurry of 
(72) 
EXAMPLE XXXIV 
3,6-Dibenzylhexahydro-8a-methoxy-5H-4a,8-(methano-
thiomethano )-2H-pyrido[3,4-e] 1,3-oxazine and 
2,4, 10, 12-Tetrabenzyl-2,4, 10, 12-tetraaza- l 5-thia-dis-
piro[5. l.5.3]hexadecan-7-one (73),(74) 
A three-necked, 50-mL, round-bottomed flask was 
fitted with a condenser, an N2 inlet, a magnetic stirrer, 
paraformaldehyde ( 1.20 g, 40.0 mmol) in methanol (20 
mL) and was heated at reflux under· N2 with stirring 
(magnetic) for 15 minutes. To this boiling mixture was 
55 added dropwise over 3.5 hours a solution of 4-thianone 
(0.58 g, 5.0 mmol), benzylamine (1.07 g, 10.0 mmol), 
glacial acetic acid (0.66'g, 11.0 mmol) in methanol (10 
mL). During the addition the paraformaldehyde slowly 
dissolved and the solution turned to .an orange-red 
60 color. The solution was heated at reflux for an addi-
tional 3.5 hours, and then allowed to stir at room tem-
perature for 48 hours. A white solid precipitated from 
the now pink solution. This solid was filtered, washed 
with methanol (5 mL) and recrystallized (2-propanol, 
65 30 mL) to afford 2,4, 10, 12-tetrabenzyl-2,4, 10, 12-tet-
raaza-15-thia-dispiro[5. l.5.3]hexadecan-7-one (0.261 g, 
8.5% relative to the amount of benzylamine used) as 
white needles: mp 172.5°-173.5° C.; IR (KBr) cm - l 
4,910,311 
38 37 
3065, 3030, 2950, 2920, 2895, 2830, 2800, 1680 (C=O), 
1500, 1457, 1097, 748, 736, 703; IH NMR (DCCh) 62.17 
[d, 1 = 10.8 Hz, 4; H, H(l,5,9, 13)ax], 2.50 [d, 1 = 8.8 Hz, 2 
H, H(3,ll)ax], 2.77 [d, 1=10.8 Hz, 4 H, H(l,5,9,13)eq], 
3.15 [s, 4 H, H(l4,16)], 3.33 [d, 1=13.0 Hz, 4 H, 5 
ArCH2], 3.49 [d, 1 = 13.0 Hz, 4 H, ArCH], 3.62 [d, 
1 = 8:S Hz, 2 H, H(3, 11)], 7.20-7.30 [m, 20 If," ArH]; 13C 
NMR (DCCh) ppm 36.43 [t, C(l4,16)], 51.26 [s, C(6,8)], 
57.63 [t, C(l,5,9,13)], 59.57 [t, ArCH2], 76;58 [t, 
C(3,l l)], 127.06 [d, p-ArC], 128.19 [d:- o- or m-ArC], 10 
128.55 [d, m- or o-ArC],-137.77 [s, i-ArC], 211.731s, 
C(7)]; 15N NMR (DCCb) ppm 43.06 [N(f,"4,10,12)]. 
The reaction mixture filtrate was evaporated (aspira-
tor) to an orange-red oil which was partitioned between 
ether (50 mL) and water (50 mL). The ether layer was 15 
treated as before to afford after recrystallization (etha-
nol, 25 mL) 3,6-Dibenzylhexahydro-8a-methoxy-5H-
4a,8-( methanothiomethano )-2H-pyrido-[3,4-e] 1,3-oxa-
zine (0.212 g, 11 %), mp 146.5°-148.0° C.; the 13C NMR 
spectrum of which was identical to that given previ- 20 
ously. The pink aqueous suspension was made alkaline 
by the addition of NaOH pellets (0.50 g, 12.5 mmol) to 
give a yellow suspension. This suspension was extracted 
with ether (4X50 mL) and the combined ether extracts 
were dried (Na2SO4, overnight). The dry ethereal solu- 25 
tion was filtered and evaporated (aspirator) and the 
resulting yellow oil was digested in boiling Skelly B 
(200 mL) for 30 minutes. The hot supernatant was de-
canted from the brown residue and evaporated (aspira-
tor followed by vaccuum pump) to leave a pale yellow 30 
oil. The 13C NMR (DCCl3) of this oil indicated that is 
was mostly N-benzyl-3-thia-7-azabicyclo[3.3. l]nonan-
9-one (0.59 g, approximately with a small amount of 
3,6-Dibenzylhexahydro-8a-methoxy-5H-4a,8-(methano-
thiomethano)-2H-pyrido[3,4-e]-l,3-oxazine present as 35 
an impurity. Analysis calculated for 3,6-dibenzylhex-
ahydro-8a-methoxy-5H-4a,8-( methanothiomethano )-
2H-pyrido-[3,4-e ]- l,3-oxazine C24H30N2O2S: C, 70.21; 
H--:-7.37; N, 6.82; S, 7.81. Found: C, 69.99; H, 7.51; N, 
6.64; S, 7.97. Analysis calculated for 2,4,10,12-tetraben- 40 
zyl-2,4, 10, 12-tetraaza- l 5-thiadispiro[5. l .5.3]hexadecan-
7-one C39H44N4SO: C, 75.94; H, 7.19; N, 9.08; S, 5.20 .. 
Found: C, 75.73; H, 7.33; N, 9.10; S, 5.20. 
;-Ph 
Ph / 
(73) 45 
g, 6.3 mmol), paraformaldehyde (1.50 g, 50.0 mmol), 
and methanol (30 mL). The apparatus was flushed with 
N2 and the mixture was heated to reflux with stirring. 
After 0.5 hours, the mixture was cooled to room tem-
perature and 4-selenanone [0.75 g, 4.6 mmol] was added 
in one portion. The mixture was again heated at reflux 
for 5 hours during which all solids dissolved and the 
resulting solution turned yellow. The solution was then 
cooled to room temperature and allowed to stir over-
night. The solvent was evaporated (aspirator) to leave a 
yellow oil which was partitioned between water (50 
mL) and ether (50 mL). The layers were separated and 
the ether layer was allowed to stand for two days at 
room temperature during which a white solid precipi-
tate formed in this solution. This was filtered and re-
crystallized (95% ethanol, 25 mL) to afford 3,6-diben-
zylhexahydro-8a-methoxy-5H-4a,8-(methanoselenome-
thano)-2H-pyrido[3,4-e]-l,3-oxazine (0.250 g) as white 
needles: mp 160.0°-160.5° C. 
The aqueous layer was cooled (ice bath) and was 
made alkaline by the addition of KOH pellets (85%, 
1.20 g, 21.4 mmol). The resulting suspension was ex-
tracted (ether, 5X40 mL) and the combined extracts 
were dried (K2CO3, overnight). Filtration, followed by 
evaporation (aspirator), afforded a yellow oil which 
was digested in hexanes (50 mL) for 0.5 hours on a 
steam bath. The hot supernatant was decanted and 
evaporated to give another yellow oil. This was dis-
solved in hot 96% ethanol (10 mL) which, upon cool-
ing, precipitated additional 3,6-dibenzylhexahydro-8a-
methoxy-5H-4a,8-(methanoselenomethano)-2H-
pyrido[3,4-e]-l,3-oxazine (67.0 mg, total: 0.3i7 g, 22%) 
mp 159°-160° C. 
The spectroscopic data for 3,6-dibenzylhexahydro-
8a-methoxy-5H-4a,8-(methanoselenomethano)-2H-
pyrido[3,4-e]-T,'3-oxazine were: IR (KBr) cm-T2840, 
1370, 1362, 1108, 1062, 1055, 762, 706; 1H NMR 
(DCCl3) 62.09 [br s, 1 H, H(8)], 2.11 [d, 1 = 11 Hz, 1 H, 
H(5)ax], 2.13 [d, 1 = 12 Hz, 1 H, H(l l)ax], 2.37 [d, 1 = 11 
Hz, 1 H, H(5)eq], 2.53 [d, 1 = 11 Hz, 1 H, H(9)ax], 2.53 
[d, 1 = 11 Hz, 1 H, ArCH2], 2.72 [d, 1 = 11 Hz, I H, 
H(4)ax], 2.93 [d, 1 = 11 Hz, I H, H(4)eq], 3.25 [s, 3 H, 
CH3O], 3.29 [d, 1 = 12 Hz, 1 H, H(l l)eq], 3.29 [d, 1 = 14 
Hz, 1 H, H(7)ax], 3.44 [d, 1 = 11 Hz, 1 H, ArCH2], 3.47 
[d, 1=11 Hz, 1 H, H(9)eq], 3.51 [d, 1=14 Hz, 1 H, 
H(7)eq], 3.53 [d, J=4 Hz, 2 H, ArCH2], 3.97 [d, 1=8 
Hz, 1 H, H(2)ax], 4.21 [d, 1 = 8 Hz, 1 H, H(2)ax], 
7.26-7.64 [m, 10 H, ArH]; 13C NMR (DCCl3) ppm 
l_ ~ EN ;a~s 
OCH, 
(74) 
50 20.11 [t, C(9)], 25.13 [t, C(ll)], 33.22 [d, C(8)], 36.84 [s, 
C(4a)], 46.51 [q, CH3O], 56.13 [t, C(4)], 56.67 [t, C(5)], 
57.26 [t, C(7)], 60.55 [t, ArCH2], 62.63 [t, ArCH2], 78.76 
[t, C(2)], 97.68 [s, C(8a)], 126.47 (d), 127.09(d), 128.11 
(d), 128.27 (d), 128.47 (d), 128.52 (d), 137.43 (s), 139.57 
EXAMPLE XXXV 
3,6-Dibenzylhexahydro-8a-methoxy-5H-4a,8-(me-
thanoselenomethano )-2H-pyrido[3,4-e]-1 J-oxazine and 
2,4, 10, 12-tetrabenzyl-i;-4, 10, 12-tetraaza-15-selenadis-
piro[5. l.5.3]hexadecan-7-one (75),(76) 
55 (s) [Are]; 15N NMR (DCCl3) ppm 36.20 [N(l2)], 47.00 
[N(3)];17Se NMR ppm 126.55 [Se(8)]. . 
In a separate experiment two other products were 
also isolated. A three-necked, 50 mL, round-bottomed 
flask was fitted with a condenser, an N2 inlet, a heating 
60 mantle, a magnetic stirrer, and two stoppers. The flask 
was charged with a solution of benzylamine (1.07 g, 
10.0 mmol), glacial acetic acid (0.62 g, 10.3 mmol), 
paraformaldehyde (1.20 g, 40.0 mmol), and methanol 
A three-necked, 50-mL, round-bottomed flask was 65 
equipped with a condenser, an N2 inlet, a heating man-
tle, and a magnetic stirrer. The flask was charged with 
benzylamine (0.67 g, 6.2 mmol), glacial acetic acid (0.38 
(25 mL). The apparatus was flushed with N2 and the 
mixture heated at reflux with stirring for 15 min. 4-
Selenanone (0.83 g, 5.0 mmol) was then added in one 
postion and the mixture heated at reflux for 5 hours. 
The supernatant turned yellow upon addition of 4-
39 
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selenanone. With continued heating, the paraformalde-
hyde slowly dissolved and the solution turned to a pink 
color. After about 3 hours, the formation of a white 
precipitate was noted. The reaction mixture was cooled 
to room temperature and stirred an additional 13 hours. 5 
The white solid was filtered from the reaction mixture, 
washed with methanol (5 mL) and recrystallized (95% 
2-propanol, 20 mL) to give 2,4, 10, 12-tetrabenzyl-
2,4, 10, 12-tetraaza-15-selenadispiro[5. l.5.3]hexadecan- 10 
7-one (57.6 mg, 1.9%) as white crystals: mp 165°-166° 
C.; IR (KBr) cm- 1 3062, 3032, 2910, 2820, 2792, 1675, 
1494, 1453, 1086, 1068, 741, 729, 697; 1H NMR (DCCl3) 
62.27 [d, 1 = 11.2 Hz, 4 H, H(l,5,9, 13)ax], 2.55 [d, 1 =8.1 
Hz, 2 H, H(3,ll)ax], 2.77 [d, 1=11.2 Hz, 4 H, 15 
H(l,5,9,13)eq], 3.17 [s, 4 H, H(l4,16)], 3.34 [d, 1=13.5 
Hz, 4 H, ArCH2], 3.50 [d, 1 = 13.5 Hz, 4 H, ArCH2], 
3.54 [d, 1 =8.1 Hz, 2 H, H(3,l l)eq], 7.20-7.30 [m, 2OH, 
ArH]; 13C NMR (DCCl3) ppm 26.67 [t, C(14,15)], 51.12 
- w [s, C(6,8)], 58.35 [t, C(l,5,9,13)], 59.58 [T, ArCH2], 
126.93 [d, p-ArC], 128.05 [d, o- or m-ArC], 128.46 [d, m-
or o-Ar~], 13717 [s, i-Ar~], 211.80 [s, C(7)]; 15N NMR 
(DCCl3) ppm 43.57. 
The reaction mixture filtrate was evaporated (aspira- 25 
tor) to leave a pink oil which was partitioned between 
ether (50 mL) and water (50 mL). The colorless ether 
layer was separated and treated as before to afford after 
recrystallization 3,6-dibenzylhexahydro-8a-methoxy-
5H-4a,8-(m.ethanoselenomethano )-2H-pyrido[3,4-e ]-1,3- 30 
oxazine (0.2030 g, 8.8%), mp 159°-160° C., the IR and 
13C NMR spectra of which were identical to that given 
previously. The pink aqueous suspension from the parti-
tioning was made alkaline by the addition of KOH pel-
lets (85%, 2.00 g, 30.3 mmol) to give an oily yellow 35 
suspension. This suspension was extracted with ether 
(5 X 40 mL) and the combined extracts dried (K2C03, 
overnight). The ethereal extracts were then filtered and 
evaporated to leave an orange oil which was digested in 40 
boiling hexanes (50 mL) for 30 min. The hot supernatant 
was decanted and evaporated to give a yellow oil. This 
was dissolved in hot 95% ethanol (30 mL), decolorized 
with carbon, and evaporated to 10 mL. Upon standing 
at - 10° C. for I day, white needles precipitated. These 45 
were filtered and air dried to afford 7-benzyl-3-selena-7-
azabicyclo[3.3. l]nonan-9-one (0.38 g, 25.8%), mp 
91 • -92° C. Analysis calculated for 3,6-dibenzylhexahy-
dro-8a-methoxy-5H-4a,8-(methanoselenomethano)-2H-
pyrido[3,4-e]-1,3-oxazine C24H30N202Se: C, 63.01; H, 5o 
6.61; N, 6.12; Se, 17.26. Found: C, 62.88; H, 6.83; N, 
6.02; Se, 16.91. 
/Ph (75) 55 
EXAMPLE XXXVI 
3,6-Dibenzylhexahydro-8a-methoxy-5H-4a,8-(methano-
thiomethano )-2H-pyrido[3,4-e ]-T,'3-oxazine 
dihydroperchlorate (77) 
A 125-mL, Erlenmeyer flask was charged with a 
solution of ketal 3,6-dibenzylhexahydro-8a-methoxy-
5H-4a, 8-( methanothiomethano )-2H-pyrido[3,4-e ]-1,3-
oxazine (l.00 g, 2.44 mmol) in benzene (20 mL). To this 
solution was added dropwise over 15 min a solution of 
HClQ4 (60%, 1.00 g, 5.97 mmol) in 2-propanol (5 mL) 
with vigorous stirring (magnetic). This precipitated the 
salt as a white powdery solid. To prevent caking of the 
precipitate it was found necessary to add additional 
2-propanol (10 mL). The mixture was stirred an addi-
tional 1 hour at room temperature. The salt was filtered, 
recrystallized (ethanol, 25 mL), and dried (Abderhal-
den, P20s, 77° C., vacuum pump, 12 hours) to afford 
3,6-dibenzylhexahydro-8a-methoxy-5H-4a,8-(methano-
thiomethano )-2H-pyrido[3,4-e ]-1,3-oxazine dihydroper-
chlorate (0.60 g~40%) as white crystals: mp 160°-162° 
C. (dee); IR(KBr) cm- 1 2760-2845 (N +-H), 1080 
(CL-0); 1H NMR (DMSO-d6) 62.17 [d, 1 = 11.7 Hz, 1 
H, H(4)ax], 2.35 [d, 1 = 11.7 Hz, l H, H(4)eq], 2.43 [d, 
J = 13.0 Hz, 1 H, H(l l)ax], 2.64 [br s, 1 H, H(8)], 2.76 [d, 
1 = 13.6 Hz, 1 H, H(9)ax], 3.00 [d, 1 = 13.0 Hz, H(l l)eq], 
3.18 [s, 3 H, CH30], 3.22 [m, 2H, H(9)eq and ArCH2], 
3.32 [d, 1 = 13.6Hz, 1 H, H(5)ax], 3.46 [d, J = 12.0 Hz, 
H(7)ax], 3.57 [d, 1=13.6 Hz, 1 H, H(5)eq], 3.79 [d, 
1 = 12.0 Hz, H(7)eq], 4.00 [d, 1 = 7.3 Hz, 1 H, H(2)ax], 
4. 19 [d, 1 = 12.0 Hz, 1 H ArCH2], 4.24 [d, 1 =7.3 Hz, I 
H, H(2)eq], 4.40 [dd, J = 12.6, 5.9 Hz, ArCH2], 4.54 [dd, 
J = 12.6, 3.9 Hz, 1 H, ArCH2], 7.25-7.39 [m, 5 H, ArH], 
7.49-7.64 [m, 5 H, ArH], 9.53 [br s, 1 H, N+-H]; iTc 
NMR (DMSO-d6) ppm 28.26 [t, C(9)], 31.34 [d-;-C(8)], 
31.80 [t, C(ll)], 37.39 [s, C(4a)], 46.36 [q, CH30], 52.33 
[T, C(4)], 54.25 [t, C(7)], 55.40 [t, C(S)], 56.21 [t, 
ArCH2], 60.20 [t, ArCH2], 78.00 [t, C(2)], 93.75 [s, 
C(Sa)], 127.14, 128.27;-129.09, 129.65, 130.60, 136.98 
[Are]. Analysis calculated for C24H30N2N202S.2 
HCl04: C, 47.14; H, 5.27; Cl, 11.59; N, 4.58; S, 5.24. 
Found: C, 47.22; H, 5.14; Cl, 11.38; N, 4.44; S, 5.47. 
(77) 
In order to illustrate the useful biological activity of 
the compounds according to the present invention, 
selected derivatives were tested_ using dog models for 
antiarrhythmic activity. The clinically used drug lido-
caine was employed as a basis for comparison. In the 
dog model an infarction was created in a small area of ;~s, 
OCH.1 
(76) 
60 the heart and thereafter an electrical pacing was admin-
istered to generate a sustained ventricular tachycardia 
(VT). This irregular bearing pattern of the heart results 
in a reduction of the heart's pumping capacity in a man-
ner now accepted as resembling symptoms observed in 
65 humans during heart attack (see: Scherlag, B. J. et al., 
Am. J. Cardiol. 1983, 51, 207; Bailey, B. B. et al, J. Med. 
Chem., 1984, 27, 759; and U.S. Pat. No. 4,581,361 for 
further details, said references incorporated herein for 
4,910,311 
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such purposes). The effects of the selected compounds was rarely eliminated. Thus, the heterocycles. claimed 
in terms of ability to reduce the rate of the ventricular in the application appear to have electrocardiology 
tachycardia or to eliminate the same (i.e., to not allow properties equal or superior to lidocaine, a clinically 
VT to be sustained) is then evaluated and compared to used drug for the treatment of victims of heart attacks. 
the drug lidocaine. The following Table contains the 5 This in combination with the possibility that the hetera 
data observed as result of the testing. atoms afford the use of a radioactive isotope for imagin-
TABLE 
Antiaarhythmic Data for Representative Compounds of the 3,7-
Diheterabic;i:clo[3.3. l ]nonanes and Derivatives 
3 mg/kg< 6 mg/kgd 
Pacing Rate of Rate of Rate of 
Compound Rate• MBP0 SVTb MBP SVT MBP SVT 
450(C)' l 7og' 450 
(50)h 
450(LY 375 
(45) 450 l()()i 330 
330(C) !6og' 
(70)h 
330 
(47) 330 240 270(NS) 
330(C) !6og' 
(70)h 
330 
(50) 330 85 300 70 
330(C) 10h 270 
390(L) 270(NS) 
360(L) 
(66) 360 95 330(NS) 
(66) 390 95 
360(C) 90" 390 
330(L) 300 
300(L) 
(66) 390 99 (NS) 
390(C) 90h 390 
390(L) 300 
390(L) 300 
(65) 390 92 210 
(65) 390 85 
390(C) 102h 390 
390(L) 330 
390(L) 
(28) 390 99 330 
390(C) 10" 390 
360(L) 360 
360(L) 
(71) 390 85 340 
360(C) 808 330 
390(L) 360 
330(Ll 
(72) 360 90 330 
(72) 390 86 
330(C) 10h 330 
(59**) 330 70 300 
(59**) 330 75 
390(C) 95h (NS) 
390(L) No VT 
360(L) 
(77) 390 98 330 
(77) 390 101 
"~can Blood Pressure during normal sinus rhythm before a VT is induced. 
hSustaincd Ventricular tachycardia 
~"3 mg of compound per kg of dog model 
"6 mg of compound per kg of dog model 
t·(C) Control before compound is added to dog model 
/( L) Lidocainc 
~MHP before compound i~ added to dog model 
h~BP during ,w,tamcd VT 
1
~BP during ~ustaincd VT 
l(NS) Nom,ustaincd VT 
'Electrically .,timupacing rate rc4uircd to induce an SVT 
••cndo-cxo i~omcr 
310 
240 
240 
270 
270 
(NS) 
210 
330 
2!0 
330 
280 
270 
330 
From the Table, it is concluded that the compound 
(45) was extremely effective in reducing the ventricular 60 
tachycardia (as compared to lidocaine) at a concentra-
tion of only 3 mg/kg. The same was true in compounds 
(28),(50), (59**),(71), and (72). In (47),(65), and (66), the 
VT generated in the dog model was virtually eliminated 
by the compound and a normal sinus rhythm was ob- 65 
served. Thus, the generated VT was not sustained in the 
presence of the compound. In contrast, the VT was 
sometimes reduced by the presence of lidocaine, but 
ing (e.g., the use of 75Se) purposes creates the possibility 
of in vivo analysis simultaneously with therapeutic 
treatment. 
In principle, it is felt that the compositions of the 
present invention can be employed by themselves, in 
combination with each other, or in combination with 
other drugs to achieve either individually or in combi-
nation the desired antiarrhythmic properties. It is envi-
sioned that the composition can be utilized and adminis-
43 
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tered in a variety of methods including by way of exam-
ple, but not limited thereto, intravenously, orally, by 
suppository, by inhalation, and the like. Furthermore, it 
is generally felt that the compositions as claimed either 
specifically possess antiarrhythmic activity or generally 5 
are broadly biologically active or the respective compo-
sitions are intermediaries to antiarrhythmic and biologi-
cally active species that are released or created in situ as 
the result of the administration of the drug. 
Having thus described and exemplified the preferred 10 
embodiments with a certain degree of particularity, it is 
to be understood that the invention is not to be limited 
to the embodiments set forth herein for purposes of 
exemplification, but is to be limited only by the scope of 
the attached claims, including a full range of equivalents 15 
to which each element thereof is entitled. 
We claim: 
1. A 3, 7-diheterabicyclo[3.3. l]nonane characterized 
44 
-continued· 
-CH,-OOCH, -CH•-Q-1 OCH3; 
or 
OCH3 
Z is Se; x- is ClO4-, CI-, Br- or r-. 
4. A 3,7-diheterabicyclo[3.3. l]nonane of claim 3 
where Ar is 
-0 
and x- is ClO4-. by the formula: 
20 5. A 3,7-diheterabicyclo[3.3. l]nonane of claim 3 
where Ar is 
where Ar is 
-0-0-CH,-Q 
s 
25 
--0 
and x- is ClOc. 
6. A 3,7-diheterabicyclo[3.3.l]nonane of claim 3 
30 where Ar is 
and x- is C!Oc. 
35 
-CH,-OOCH, m -CH,-Q-OCH, 
7. A 3, 7-diheterabicyclo[3.3. l]nonane of claim 3 
40 where Ar is OCH.1 
Z is Se; X- is CIO4-, CJ-, Br- or I-; and Y is -OH 
or -OCH3. 
2. A 3,7-diheterabicyclo[3.3. l]nonane of claim 1 
where Ar is 
-0 
X- is CIO4-, and Y is -OH. 
3. A 3, 7-diheterabicyclo[3.3. I ]nonane characterized 
by the formula: 
where Ar is 
-0-0-CH,-Q 
45 
50 
55 
and X- is CIO4-. 
8. A 3,7-diheterabicyclo[3.3. l]nonane of claim 3 
where Ar is 
and X- is CIO4-. 
9. A 3, 7-diheterabicyclo[3.3. l]nonane characterized 
60 by the formulae: 
65 
45 
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46 
-continued 
H ,Ar 
x-+ I , Ar H x-
H~N -, / i~ 
-.... I Ar 
Y ~rny~z 
y y 
where Ar is 
-0-{)-cH,-Q. 
-CH,-OOCH,, CH,-Q-OCH> 
OCH3 
or o-CIC6H4 or p-ClC6H4; Z is Se; X - is Cl04 - , Cl - , 
Br- or I-; and Y is -H, -OH or -OCH3. 
5 
10. A 3,7-diheterabicyclo[3.3.l]nonane of claim 9 
where Ar is 
-0--0· 
p-ClC6H4, or o-ClC6H4, 
11. A 3, 7-diheterabicyclo[3.3. l]nonane of claim 10 
lO where Ar is 
15 
20 
25 
-0 
12. A 3,7-diheterabicyclo[3.3.l]nonane of claim 10 
where Ar is 
-0 
13. A 3,7-diheterabicyclo[3.3. l]nonane of claim 10 
where Ar is p-ClC6H4, 
14. A 3,7-diheterabicyclo[3.3.l]nonane of claim 10 
where Ar is o-ClC6H4. 
30 15. A 3,7-diheterabicyclo[3.3.l]nonane of claim 11 
wherein the compound is an acid salt and X- is Cl04 - . 
16. A 3,7-diheterabicyclo[3.3. l]nonane of claim 12 
wherein the compound is an acid salt and X- is Cl04 - . 
17. A 3,7-diheterabicyclo[3.3. l]nonane of claim 13 
35 wherein the compound is an acid salt and X- is Cl04 - . 
18. A 3,7-diheterabicyclo[3.3. l]nonane of claim 14 
wherein the compound is an acid salt and X- is Cl04-. 
* * * * * 
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